A	O
novel	O
transcription	B-protein
factor	I-protein
regulates	O
expression	O
of	O
the	O
vacuolar	B-protein
H+-ATPase	I-protein
B2	I-protein
subunit	I-protein
through	O
AP-2	B-DNA
sites	I-DNA
during	O
monocytic	O
differentiation	O
.	O

During	O
monocyte-to-macrophage	O
differentiation	O
,	O
the	O
cellular	O
content	O
of	O
vacuolar	B-protein
H+-ATPase	I-protein
(	O
V-ATPase	B-protein
)	O
increases	O
more	O
than	O
4-fold	O
.	O

We	O
have	O
shown	O
previously	O
that	O
amplified	O
expression	O
of	O
the	O
B2	B-protein
subunit	I-protein
of	O
the	O
V-ATPase	B-protein
occurs	O
solely	O
by	O
increased	O
transcription	O
,	O
and	O
that	O
the	O
5'-untranslated	B-DNA
region	I-DNA
of	O
the	O
B2	B-DNA
gene	I-DNA
,	O
containing	O
multiple	O
consensus	B-DNA
binding	I-DNA
sites	I-DNA
for	O
the	O
transcription	B-protein
factors	I-protein
AP-2	B-protein
and	O
Sp1	B-protein
,	O
is	O
required	O
for	O
this	O
expression	O
.	O

The	O
present	O
study	O
demonstrates	O
that	O
AP-2	B-DNA
binding	I-DNA
sequences	I-DNA
are	O
essential	O
for	O
increased	O
transcription	O
from	O
the	O
B2	B-DNA
promoter	I-DNA
during	O
monocyte-macrophage	O
differentiation	O
and	O
that	O
AP-2	B-protein
,	O
expressed	O
exogenously	O
in	O
THP-1	B-cell_line
and	O
other	O
cells	O
,	O
activates	O
transcription	O
from	O
the	O
B2	B-DNA
promoter	I-DNA
.	O

In	O
mobility	O
shift	O
assays	O
,	O
a	O
nuclear	B-protein
factor	I-protein
from	O
THP-1	B-cell_line
and	O
U-937	B-cell_line
cells	I-cell_line
was	O
identified	O
that	O
binds	O
to	O
several	O
AP-2	B-DNA
response	I-DNA
elements	I-DNA
within	O
the	O
B2	B-DNA
promoter	I-DNA
,	O
but	O
does	O
not	O
react	O
with	O
AP-2	B-protein
antibodies	I-protein
,	O
and	O
has	O
a	O
DNA	B-DNA
sequence	I-DNA
binding	O
affinity	O
profile	O
that	O
differs	O
from	O
AP-2	B-protein
.	O

These	O
findings	O
suggest	O
that	O
a	O
novel	O
AP-2-like	B-protein
transcription	I-protein
factor	I-protein
is	O
responsible	O
for	O
V-ATPase	B-protein
B	I-protein
subunit	I-protein
amplification	O
during	O
monocyte	O
differentiation	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

1	NULL
,	NULL
Issue	NULL
of	NULL
January	NULL
3	NULL
,	NULL
pp	NULL
.	NULL

174-181	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
A	NULL
Novel	NULL
Transcription	NULL
Factor	NULL
Regulates	NULL
Expression	NULL
of	NULL
the	NULL
Vacuolar	NULL
H*-ATPase	NULL
B2	NULL
Subunit	NULL
through	NULL
AP-2	NULL
Sites	NULL
during	NULL
Monocytic	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
August	NULL
6	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
October	NULL
21	NULL
,	NULL
1996	NULL
)	NULL
Beth	NULL
S.	NULL
Lee	NULL
#	NULL
§	NULL
,	NULL
Irina	NULL
Krits	NULL
}	NULL
,	NULL
Monica	NULL
K.	NULL
Crane-Zelkovict	NULL
,	NULL
and	NULL
Stephen	NULL
L.	NULL
Gluck	NULL
#	NULL
]	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Medicine/	NULL
Renal	NULL
Division	NULL
,	NULL
(	NULL
Department	NULL
of	NULL
Cell	NULL
Biology	NULL
and	NULL
Physiology	NULL
,	NULL
and	NULL
the	NULL
{	NULL
George	NULL
M.	NULL
O'Brien	NULL
Center	NULL
for	NULL
Kidney	NULL
and	NULL
Urological	NULL
Diseases	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
During	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
,	NULL
the	NULL
cellular	NULL
content	NULL
of	NULL
vacuolar	NULL
H*-ATPase	NULL
(	NULL
V-ATPase	NULL
)	NULL
increases	NULL
more	NULL
than	NULL
4-fold	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
amplified	NULL
expression	NULL
of	NULL
the	NULL
B2	NULL
subunit	NULL
of	NULL
the	NULL
V-ATPase	NULL
occurs	NULL
solely	NULL
by	NULL
increased	NULL
transcription	NULL
,	NULL
and	NULL
that	NULL
the	NULL
-untranslated	NULL
region	NULL
of	NULL
the	NULL
B2	NULL
gene	NULL
,	NULL
containing	NULL
multiple	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
AP-2	NULL
and	NULL
Sp1	NULL
,	NULL
is	NULL
required	NULL
for	NULL
this	NULL
expression	NULL
.	NULL

The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
AP-2	NULL
binding	NULL
sequences	NULL
are	NULL
essential	NULL
for	NULL
increased	NULL
transcription	NULL
from	NULL
the	NULL
B2	NULL
promoter	NULL
during	NULL
monocyte-macrophage	NULL
differentiation	NULL
and	NULL
that	NULL
AP-2	NULL
,	NULL
expressed	NULL
exogenously	NULL
in	NULL
THP-1	NULL
and	NULL
other	NULL
cells	NULL
,	NULL
activates	NULL
transcription	NULL
from	NULL
the	NULL
B2	NULL
promoter	NULL
.	NULL

In	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
from	NULL
THP-1	NULL
and	NULL
U-937	NULL
cells	NULL
was	NULL
identified	NULL
that	NULL
binds	NULL
to	NULL
several	NULL
AP-2	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
B2	NULL
promoter	NULL
,	NULL
but	NULL
does	NULL
not	NULL
react	NULL
with	NULL
AP-2	NULL
antibodies	NULL
,	NULL
and	NULL
has	NULL
a	NULL
DNA	NULL
sequence	NULL
binding	NULL
affinity	NULL
profile	NULL
that	NULL
differs	NULL
from	NULL
AP-2	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
a	NULL
novel	NULL
AP-2-like	NULL
transcription	NULL
factor	NULL
is	NULL
responsible	NULL
for	NULL
V-ATPase	NULL
B	NULL
subunit	NULL
amplification	NULL
during	NULL
monocyte	NULL
differentiation	NULL
.	NULL

The	NULL
mammalian	NULL
vacuolar	NULL
H*ATPase	NULL
,	NULL
or	NULL
V-ATPase	NULL
,	NULL
``	NULL
is	NULL
a	NULL
multisubunit	NULL
complex	NULL
that	NULL
transports	NULL
protons	NULL
electrogenically	NULL
across	NULL
the	NULL
membranes	NULL
of	NULL
intracellular	NULL
endocytic	NULL
and	NULL
secretory	NULL
compartments	NULL
in	NULL
all	NULL
eukaryotic	NULL
cells	NULL
and	NULL
the	NULL
plasma	NULL
membrane	NULL
in	NULL
certain	NULL
specialized	NULL
cell	NULL
types	NULL
.	NULL

Its	NULL
role	NULL
in	NULL
acidifying	NULL
organelles	NULL
is	NULL
required	NULL
for	NULL
protein	NULL
transport	NULL
,	NULL
processing	NULL
,	NULL
and	NULL
degradation	NULL
.	NULL

In	NULL
the	NULL
plasma	NULL
membrane	NULL
,	NULL
the	NULL
V-ATPase	NULL
participates	NULL
in	NULL
transcellular	NULL
transport	NULL
of	NULL
H*	NULL
and	NULL
other	NULL
ions	NULL
and	NULL
in	NULL
defending	NULL
cytosolic	NULL
pH	NULL
.	NULL

The	NULL
V-ATPase	NULL
is	NULL
similar	NULL
in	NULL
structure	NULL
to	NULL
the	NULL
FoF	NULL
,	NULL
-ATPases	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
and	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
distinct	NULL
macrodomains	NULL
.	NULL

The	NULL
trans-membrane	NULL
domain	NULL
(	NULL
V	NULL
,	NULL
,	NULL
)	NULL
is	NULL
composed	NULL
of	NULL
proteolipids	NULL
and	NULL
other	NULL
integral	NULL
membrane	NULL
proteins	NULL
and	NULL
transmits	NULL
protons	NULL
through	NULL
the	NULL
lipid	NULL
bilayer	NULL
(	NULL
3-7	NULL
)	NULL
.	NULL

The	NULL
cytosolic	NULL
domain	NULL
of	NULL
the	NULL
enyzme	NULL
(	NULL
V	NULL
;	NULL
)	NULL
is	NULL
composed	NULL
of	NULL
three	NULL
copies	NULL
each	NULL
of	NULL
the	NULL
``	NULL
A	NULL
``	NULL
subunit	NULL
(	NULL
70	NULL
kDa	NULL
)	NULL
and	NULL
the	NULL
``	NULL
B	NULL
``	NULL
subunit	NULL
(	NULL
56-58	NULL
kDa	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
``	NULL
C	NULL
``	NULL
(	NULL
42	NULL
kDa	NULL
)	NULL
,	NULL
``	NULL
D	NULL
``	NULL
(	NULL
83	NULL
kDa	NULL
)	NULL
,	NULL
``	NULL
E	NULL
``	NULL
(	NULL
31	NULL
kDa	NULL
)	NULL
,	NULL
and	NULL
``	NULL
F	NULL
``	NULL
(	NULL
14	NULL
kDa	NULL
)	NULL
subunits	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
AR32087	NULL
,	NULL
DK38848	NULL
,	NULL
DK09976	NULL
,	NULL
and	NULL
DK45181	NULL
and	NULL
by	NULL
a	NULL
research	NULL
grant	NULL
from	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
(	NULL
to	NULL
B.	NULL
S.	NULL
L	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Medicine	NULL
,	NULL
Renal	NULL
Division	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
660	NULL
South	NULL
Euclid	NULL
Ave.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
68110	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
814-862-2728	NULL
;	NULL
Fax	NULL
:	NULL
314-862-8287	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
V-ATPase	NULL
,	NULL
vacuolar	NULL
H*ATPase	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
TPA	NULL
,	NULL
tetradecanoylphorbol-13-acetate	NULL
.	NULL

(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

8	NULL
)	NULL
.	NULL

The	NULL
A	NULL
subunit	NULL
contains	NULL
the	NULL
site	NULL
of	NULL
catalytic	NULL
ATP-binding	NULL
site	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
although	NULL
the	NULL
B	NULL
subunit	NULL
likely	NULL
participates	NULL
in	NULL
catalysis	NULL
(	NULL
11	NULL
)	NULL
and	NULL
may	NULL
have	NULL
a	NULL
regulatory	NULL
role	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Two	NULL
isoforms	NULL
of	NULL
the	NULL
B	NULL
subunit	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
mammals	NULL
(	NULL
14-16	NULL
)	NULL
.	NULL

They	NULL
are	NULL
encoded	NULL
by	NULL
different	NULL
genes	NULL
and	NULL
differ	NULL
in	NULL
amino	NULL
acid	NULL
sequence	NULL
at	NULL
the	NULL
amino	NULL
and	NULL
carboxyl	NULL
termini	NULL
,	NULL
although	NULL
no	NULL
functional	NULL
differences	NULL
have	NULL
yet	NULL
been	NULL
identified	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
B1	NULL
isoform	NULL
is	NULL
restricted	NULL
to	NULL
only	NULL
a	NULL
few	NULL
tissues	NULL
;	NULL
it	NULL
is	NULL
found	NULL
at	NULL
highest	NULL
levels	NULL
in	NULL
kidney	NULL
and	NULL
placenta	NULL
.	NULL

The	NULL
B2	NULL
isoform	NULL
is	NULL
ubiquitously	NULL
expressed	NULL
and	NULL
is	NULL
most	NULL
abundant	NULL
in	NULL
kidney	NULL
and	NULL
brain	NULL
.	NULL
``	NULL

Cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
,	NULL
including	NULL
monocytes	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
osteoclasts	NULL
,	NULL
express	NULL
V-ATPase	NULL
with	NULL
a	NULL
B2	NULL
subunit	NULL
both	NULL
in	NULL
intracellular	NULL
compartments	NULL
and	NULL
on	NULL
their	NULL
plasma	NULL
membranes	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Macrophages	NULL
express	NULL
the	NULL
V-ATPase	NULL
on	NULL
their	NULL
plasma	NULL
membranes	NULL
to	NULL
aid	NULL
in	NULL
intracellular	NULL
pH	NULL
regulation	NULL
when	NULL
exposed	NULL
to	NULL
acidic	NULL
environments	NULL
such	NULL
as	NULL
abscessed	NULL
tissue	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
;	NULL
osteoclasts	NULL
employ	NULL
the	NULL
V-ATPase	NULL
in	NULL
the	NULL
ruffled	NULL
membrane	NULL
to	NULL
generate	NULL
an	NULL
acidic	NULL
microenvironment	NULL
required	NULL
for	NULL
bone	NULL
resorption	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
prior	NULL
studies	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
the	NULL
cellular	NULL
content	NULL
of	NULL
V-ATPase	NULL
subunits	NULL
increases	NULL
by	NULL
as	NULL
much	NULL
as	NULL
5-fold	NULL
in	NULL
native	NULL
monocytes	NULL
and	NULL
by	NULL
3-4-fold	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Both	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
mechanisms	NULL
of	NULL
amplification	NULL
were	NULL
observed	NULL
among	NULL
the	NULL
different	NULL
V-ATPase	NULL
subunits	NULL
examined	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
B2	NULL
subunit	NULL
(	NULL
approx-imately	NULL
3.5-fold	NULL
)	NULL
occurred	NULL
solely	NULL
by	NULL
transcriptional	NULL
activation	NULL
.	NULL

We	NULL
isolated	NULL
and	NULL
characterized	NULL
the	NULL
proximal	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
B2	NULL
gene	NULL
and	NULL
found	NULL
that	NULL
the	NULL
DNA	NULL
in	NULL
the	NULL
5'-untranslated	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
was	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
during	NULL
monocyte	NULL
differentiation	NULL
and	NULL
that	NULL
this	NULL
region	NULL
contained	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
AP-2	NULL
.	NULL

AP-2	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
a	NULL
M	NULL
,	NULL
=	NULL
52,000	NULL
transcription	NULL
factor	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
that	NULL
had	NULL
unique	NULL
patterns	NULL
of	NULL
expression	NULL
in	NULL
different	NULL
tissues	NULL
during	NULL
embryonic	NULL
development	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Isoforms	NULL
of	NULL
AP-2	NULL
were	NULL
later	NULL
identified	NULL
that	NULL
were	NULL
products	NULL
of	NULL
alternative	NULL
splicing	NULL
of	NULL
RNA	NULL
from	NULL
a	NULL
single	NULL
gene	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
Moser	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
isolated	NULL
murine	NULL
genomic	NULL
and	NULL
cDNA	NULL
clones	NULL
for	NULL
a	NULL
homologue	NULL
of	NULL
AP-2	NULL
,	NULL
designated	NULL
AP-2	NULL
$	NULL
,	NULL
encoded	NULL
by	NULL
a	NULL
second	NULL
gene	NULL
.	NULL

cDNAs	NULL
from	NULL
the	NULL
two	NULL
genes	NULL
share	NULL
an	NULL
overall	NULL
identity	NULL
of	NULL
76	NULL
%	NULL
at	NULL
the	NULL
amino	NULL
acid	NULL
level	NULL
,	NULL
with	NULL
the	NULL
strongest	NULL
homology	NULL
in	NULL
the	NULL
carboxyl-terminal	NULL
DNA	NULL
binding/dimerization	NULL
domain	NULL
(	NULL
85	NULL
%	NULL
identity	NULL
,	NULL
92	NULL
%	NULL
similarity	NULL
)	NULL
.	NULL

Both	NULL
AP-28	NULL
and	NULL
the	NULL
original	NULL
AP-2	NULL
isolate	NULL
(	NULL
now	NULL
designated	NULL
AP-2	NULL
«	NULL
)	NULL
bind	NULL
to	NULL
the	NULL
DNA	NULL
consensus	NULL
sequence	NULL
although	NULL
many	NULL
variants	NULL
of	NULL
this	NULL
sequence	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
isoforms	NULL
is	NULL
unclear	NULL
;	NULL
both	NULL
AP-28B	NULL
and	NULL
AP-2	NULL
«	NULL
activate	NULL
transcription	NULL
to	NULL
an	NULL
equal	NULL
extent	NULL
,	NULL
and	NULL
the	NULL
patterns	NULL
of	NULL
expression	NULL
*	NULL
R.	NULL
D.	NULL
Nelson	NULL
,	NULL
D.	NULL
M.	NULL
Underhill	NULL
,	NULL
S.	NULL
P.	NULL
Hmiel	NULL
,	NULL
S.	NULL
Bae	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Gluck	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
.	NULL

174	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbc/	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
AP-2	NULL
Binding	NULL
Sites	NULL
Regulate	NULL
V-ATPase	NULL
B2	NULL
Subunit	NULL
Expression	NULL
175	NULL
of	NULL
both	NULL
genes	NULL
are	NULL
highly	NULL
similar	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
AP-2	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
V-ATPase	NULL
B2	NULL
gene	NULL
are	NULL
functional	NULL
in	NULL
vivo	NULL
and	NULL
are	NULL
required	NULL
for	NULL
regulation	NULL
of	NULL
B2	NULL
expression	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

We	NULL
identify	NULL
a	NULL
nuclear	NULL
factor	NULL
from	NULL
human	NULL
monocytic	NULL
cell	NULL
lines	NULL
that	NULL
binds	NULL
to	NULL
AP-2	NULL
consensus	NULL
binding	NULL
sites	NULL
but	NULL
is	NULL
distinct	NULL
from	NULL
AP-2	NULL
«	NULL
and	NULL
AP-2	NULL
$	NULL
as	NULL
determined	NULL
by	NULL
DNA	NULL
binding	NULL
affinity	NULL
and	NULL
immunological	NULL
reactivity	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-Unless	NULL
specified	NULL
otherwise	NULL
,	NULL
all	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
and	NULL
were	NULL
reagent	NULL
grade	NULL
.	NULL

Isolation	NULL
and	NULL
Culture	NULL
of	NULL
Cells-THP-1	NULL
and	NULL
U-987	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
,	NULL
and	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Hyclone	NULL
;	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
50	NULL
ug/ml	NULL
gentamicin	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
incuba-tor	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
addition	NULL
of	NULL
160	NULL
nM	NULL
tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
,	NULL
29	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
Footprinting-DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
the	NULL
noncoding	NULL
strand	NULL
of	NULL
probe	NULL
-338	NULL
to	NULL
+84	NULL
was	NULL
radiolabeled	NULL
.	NULL

Promoter	NULL
Constructs-The	NULL
isolation	NULL
and	NULL
sequence	NULL
of	NULL
the	NULL
B2	NULL
gene	NULL
proximal	NULL
promoter	NULL
was	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

B2	NULL
promoter	NULL
fragments	NULL
were	NULL
inserted	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
in	NULL
the	NULL
vector	NULL
pGL8	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
B2	NULL
fragment	NULL
-817	NULL
to	NULL
-52	NULL
,	NULL
which	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
vector	NULL
pGL2	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
-817	NULL
to	NULL
-124	NULL
site	NULL
1	NULL
mutant	NULL
was	NULL
created	NULL
by	NULL
using	NULL
restriction	NULL
enzymes	NULL
to	NULL
excise	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
wild-type	NULL
promoter	NULL
containing	NULL
binding	NULL
site	NULL
1	NULL
and	NULL
then	NULL
ligating	NULL
in	NULL
synthetic	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
mutant	NULL
site	NULL
.	NULL

In	NULL
this	NULL
manner	NULL
,	NULL
the	NULL
core	NULL
AP-2	NULL
binding	NULL
sequence	NULL
of	NULL
site	NULL
1	NULL
was	NULL
changed	NULL
from	NULL
5-GGTCTGGCC-3	NULL
'	NULL
to	NULL
5'-AATATAAAA-3	NULL
'	NULL
.	NULL

Recombinant	NULL
human	NULL
AP-2	NULL
«	NULL
was	NULL
expressed	NULL
from	NULL
an	NULL
SV40-derived	NULL
promoter	NULL
in	NULL
the	NULL
vector	NULL
pSAP2	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
M.	NULL
Tainsky	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
M.D	NULL
.	NULL

Anderson	NULL
Cancer	NULL
Center	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
Cells-Transfections	NULL
of	NULL
THP-1	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
,	NULL
30	NULL
)	NULL
.	NULL

For	NULL
AP-2	NULL
«	NULL
co-transfection	NULL
experiments	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
B2	NULL
promoter-luciferase	NULL
reporter	NULL
plasmid	NULL
plus	NULL
2	NULL
ug	NULL
of	NULL
pRSVeat	NULL
,	NULL
a	NULL
vector	NULL
for	NULL
expression	NULL
of	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
used	NULL
to	NULL
normalize	NULL
luciferase	NULL
activity	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
were	NULL
co-transfected	NULL
with	NULL
0-2	NULL
ug	NULL
of	NULL
pSAP2	NULL
.	NULL

Cloning	NULL
vector	NULL
pGEM-5Z	NULL
was	NULL
added	NULL
to	NULL
the	NULL
DNA	NULL
mixtures	NULL
as	NULL
needed	NULL
to	NULL
equalize	NULL
the	NULL
DNA	NULL
concentration	NULL
among	NULL
transfections	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
prepared	NULL
for	NULL
luciferase	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

The	NULL
experiments	NULL
using	NULL
transfection	NULL
and	NULL
subsequent	NULL
differentiation	NULL
of	NULL
THP-1	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Luciferase	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
,	NULL
82	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
AP-2	NULL
«	NULL
cDNAs	NULL
from	NULL
THP-1	NULL
Cells-THP-1	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
TPA	NULL
for	NULL
24	NULL
h	NULL
as	NULL
described	NULL
above	NULL
.	NULL

mRNA	NULL
was	NULL
isolated	NULL
using	NULL
the	NULL
FastTrack	NULL
messenger	NULL
RNA	NULL
isolation	NULL
kit	NULL
(	NULL
Invitrogen	NULL
;	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

cDNA	NULL
synthesis	NULL
and	NULL
subcloning	NULL
into	NULL
the	NULL
A	NULL
vector	NULL
Uni-ZAP	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
cDNA	NULL
synthesis	NULL
kit	NULL
(	NULL
Stratagene	NULL
;	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
screening	NULL
of	NULL
this	NULL
library	NULL
,	NULL
1	NULL
X	NULL
10°	NULL
plaques	NULL
on	NULL
nitrocellulose	NULL
filters	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
were	NULL
probed	NULL
with	NULL
a	NULL
*°P-labeled	NULL
361-base	NULL
pair	NULL
Pstl	NULL
cDNA	NULL
fragment	NULL
corresponding	NULL
to	NULL
a	NULL
region	NULL
within	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
human	NULL
AP-2	NULL
«	NULL
(	NULL
spanning	NULL
amino	NULL
acid	NULL
residues	NULL
278-399	NULL
;	NULL
EMBL/GenBank	NULL
accession	NULL
number	NULL
Y00229	NULL
)	NULL
.	NULL

Following	NULL
hybridization	NULL
of	NULL
the	NULL
probe	NULL
,	NULL
filters	NULL
were	NULL
washed	NULL
under	NULL
final	NULL
conditions	NULL
of	NULL
42EC	NULL
in	NULL
2	NULL
X	NULL
SSPE	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

Plaques	NULL
were	NULL
purified	NULL
through	NULL
multiple	NULL
rounds	NULL
of	NULL
screening	NULL
,	NULL
and	NULL
pBluescript	NULL
plasmids	NULL
containing	NULL
the	NULL
inserts	NULL
of	NULL
interest	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
Uni-ZAP	NULL
vector	NULL
using	NULL
ExAssist	NULL
interference-resistant	NULL
helper	NULL
phage	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
Gel	NULL
Mobility	NULL
Shift	NULL
Assays-Nuclear	NULL
extracts	NULL
from	NULL
dividing	NULL
or	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
83	NULL
)	NULL
,	NULL
except	NULL
nuclear	NULL
proteins	NULL
were	NULL
further	NULL
purified	NULL
by	NULL
precipitation	NULL
with	NULL
55	NULL
%	NULL
saturated	NULL
ammonium	NULL
sulfate	NULL
prior	NULL
to	NULL
dialysis	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
other	NULL
cell	NULL
types	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
of	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
for	NULL
small	NULL
cell	NULL
numbers	NULL
.	NULL

For	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
end-labeled	NULL
with	NULL
[	NULL
y-*	NULL
``	NULL
PIATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
oligonucleotide	NULL
pair	NULL
containing	NULL
the	NULL
AP-2	NULL
binding	NULL
sequence	NULL
5'-GATCGAACT-GACCGCCCGCGGCCCGT-3	NULL
'	NULL
(	NULL
core	NULL
binding	NULL
site	NULL
underlined	NULL
)	NULL
from	NULL
the	NULL
human	NULL
metallothionein	NULL
IIa	NULL
distal	NULL
basal	NULL
level	NULL
element	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
.	NULL

The	NULL
B2	NULL
promoter	NULL
site	NULL
1	NULL
oligonucleotide	NULL
was	NULL
composed	NULL
of	NULL
the	NULL
sequence	NULL
5'-CAAGCAGGTCTGGCCCCAGCGGCGCG-3	NULL
'	NULL
corresponding	NULL
to	NULL
-173	NULL
to	NULL
-148	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
start	NULL
of	NULL
translation	NULL
.	NULL

The	NULL
site	NULL
5	NULL
oligonucleotide	NULL
was	NULL
composed	NULL
of	NULL
the	NULL
sequences	NULL
5'-GCCTCGGC-CGCGGGCCGCCTT-3	NULL
'	NULL
corresponding	NULL
to	NULL
-78	NULL
to	NULL
-58	NULL
.	NULL

The	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
Spl	NULL
consensus	NULL
binding	NULL
sequence	NULL
5'-ATTC-GATCGGGGCGGGGCGAGC-3	NULL
'	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
.	NULL

Purified	NULL
recombinant	NULL
Spl	NULL
and	NULL
AP-2	NULL
«	NULL
were	NULL
obtained	NULL
from	NULL
Promega	NULL
.	NULL

Approximately	NULL
30	NULL
fmol	NULL
of	NULL
end-labeled	NULL
oligonucleotides	NULL
(	NULL
5	NULL
X	NULL
10*	NULL
Cerenkov	NULL
counts	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
1-6	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
(	NULL
final	NULL
concentration	NULL
)	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
4	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.05	NULL
mg/ml	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
«	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
20-min	NULL
incubation	NULL
at	NULL
room	NULL
tem-perature	NULL
,	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
4	NULL
%	NULL
nondenatur-ing	NULL
acrylamide	NULL
gel	NULL
,	NULL
which	NULL
was	NULL
then	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
.	NULL

Supershift	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
1-5	NULL
ug	NULL
of	NULL
antibody	NULL
against	NULL
AP-2	NULL
«	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
;	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
nuclear	NULL
extract	NULL
mixtures	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
radiolabeled	NULL
probe	NULL
and	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Oligonucleotide	NULL
competition	NULL
reactions	NULL
were	NULL
performed	NULL
by	NULL
preincubating	NULL
the	NULL
nuclear	NULL
extract	NULL
with	NULL
unlabeled	NULL
oligonucleotides	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
radioactive	NULL
probe	NULL
.	NULL

Statistical	NULL
Analysis-Data	NULL
on	NULL
promoter	NULL
activity	NULL
are	NULL
presented	NULL
as	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

and	NULL
were	NULL
analyzed	NULL
by	NULL
one-way	NULL
analysis	NULL
of	NULL
variance	NULL
using	NULL
SigmaStat	NULL
(	NULL
Jandel	NULL
Scientific	NULL
;	NULL
San	NULL
Rafael	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
p	NULL
value	NULL
of	NULL
0.05	NULL
was	NULL
used	NULL
as	NULL
the	NULL
threshold	NULL
criterion	NULL
for	NULL
statistical	NULL
significance	NULL
.	NULL

RESULTS	NULL
The	NULL
5'-Untranslated	NULL
Region	NULL
of	NULL
the	NULL
B2	NULL
Promoter	NULL
Contains	NULL
Multiple	NULL
AP-2	NULL
Binding	NULL
Sites-In	NULL
previous	NULL
DNase	NULL
I	NULL
footprinting	NULL
studies	NULL
in	NULL
which	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
B2	NULL
promoter	NULL
was	NULL
labeled	NULL
(	NULL
18	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
5'-untranslated	NULL
region	NULL
and	NULL
proximal	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
B2	NULL
promoter	NULL
contained	NULL
five	NULL
sequences	NULL
capable	NULL
of	NULL
binding	NULL
purified	NULL
AP-2	NULL
«	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
performed	NULL
footprinting	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
non-coding	NULL
strand	NULL
was	NULL
labeled	NULL
.	NULL

We	NULL
identified	NULL
three	NULL
additional	NULL
potential	NULL
AP-2	NULL
binding	NULL
sites	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
five	NULL
AP-2	NULL
binding	NULL
sites	NULL
noted	NULL
previously	NULL
are	NULL
designated	NULL
sites	NULL
2	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
.	NULL

Of	NULL
the	NULL
three	NULL
newly	NULL
identified	NULL
AP-2	NULL
binding	NULL
sequences	NULL
,	NULL
two	NULL
(	NULL
sites	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
composed	NULL
of	NULL
the	NULL
sequence	NULL
5'-GC-CGRRGCC-3	NULL
'	NULL
(	NULL
where	NULL
R	NULL
indicates	NULL
purine	NULL
)	NULL
,	NULL
were	NULL
found	NULL
embedded	NULL
within	NULL
Spl	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
most	NULL
proximal	NULL
site	NULL
(	NULL
site	NULL
1	NULL
)	NULL
contained	NULL
a	NULL
near-perfect	NULL
palindromic	NULL
sequence	NULL
5-GGTCTG-GCC-3	NULL
'	NULL
.	NULL

Purified	NULL
AP-2	NULL
«	NULL
also	NULL
bound	NULL
at	NULL
the	NULL
G	NULL
+	NULL
C-rich	NULL
region	NULL
of	NULL
transcriptional	NULL
initiation	NULL
,	NULL
although	NULL
this	NULL
site	NULL
would	NULL
not	NULL
be	NULL
expected	NULL
to	NULL
be	NULL
active	NULL
in	NULL
vivo	NULL
due	NULL
to	NULL
interference	NULL
from	NULL
the	NULL
basal	NULL
transcription	NULL
complex	NULL
.	NULL

Promoter	NULL
deletion	NULL
studies	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
discussed	NULL
below	NULL
)	NULL
show	NULL
that	NULL
this	NULL
site	NULL
does	NULL
not	NULL
mediate	NULL
AP-2-en-hanced	NULL
transcription	NULL
in	NULL
vivo	NULL
.	NULL

Expression	NULL
of	NULL
Exogenous	NULL
AP-2	NULL
Increases	NULL
Expression	NULL
from	NULL
B2	NULL
Gene	NULL
Promoters-To	NULL
determine	NULL
whether	NULL
AP-2	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
B2	NULL
promoter	NULL
in	NULL
vivo	NULL
and	NULL
mediate	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
co-transfected	NULL
into	NULL
undifferentiated	NULL
THP-1	NULL
cells	NULL
up	NULL
to	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
plasmid	NULL
pSAP2	NULL
,	NULL
for	NULL
exogenous	NULL
expression	NULL
of	NULL
human	NULL
AP-2a	NULL
«	NULL
(	NULL
85	NULL
)	NULL
,	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
one	NULL
of	NULL
several	NULL
B2	NULL
promoter-luciferase	NULL
reporter	NULL
constructs	NULL
.	NULL

Five	NULL
promoter	NULL
constructs	NULL
were	NULL
used	NULL
.	NULL

1	NULL
)	NULL
A	NULL
fragment	NULL
spanning	NULL
from	NULL
-317	NULL
to	NULL
+30	NULL
containing	NULL
AP-2	NULL
binding	NULL
sites	NULL
1-8	NULL
;	NULL
2	NULL
)	NULL
fragment	NULL
-317	NULL
to	NULL
-52	NULL
containing	NULL
AP-2	NULL
binding	NULL
sites	NULL
1-5	NULL
;	NULL
3	NULL
)	NULL
fragment	NULL
-317	NULL
to	NULL
-124	NULL
containing	NULL
site	NULL
1	NULL
only	NULL
;	NULL
4	NULL
)	NULL
-317	NULL
to	NULL
-199	NULL
,	NULL
containing	NULL
no	NULL
AP-2	NULL
binding	NULL
sites	NULL
except	NULL
the	NULL
sequence	NULL
at	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
;	NULL
and	NULL
5	NULL
)	NULL
-817	NULL
to	NULL
-124mut	NULL
,	NULL
containing	NULL
a	NULL
mutated	NULL
AP-2	NULL
binding	NULL
site	NULL
1	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Co-transfection	NULL
of	NULL
pSAP2	NULL
with	NULL
the	NULL
promoter	NULL
constructs	NULL
in	NULL
THP-1	NULL
cells	NULL
resulted	NULL
in	NULL
up	NULL
to	NULL
4A-fold	NULL
greater	NULL
luciferase	NULL
activity	NULL
than	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
control	NULL
plasmid	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
at	NULL
least	NULL
one	NULL
AP-2	NULL
binding	NULL
site	NULL
was	NULL
required	NULL
for	NULL
this	NULL
activation	NULL
,	NULL
since	NULL
deletion	NULL
or	NULL
mutation	NULL
of	NULL
all	NULL
sites	NULL
abolished	NULL
the	NULL
effect	NULL
of	NULL
exogenous	NULL
AP-2	NULL
.	NULL

Site	NULL
1	NULL
alone	NULL
was	NULL
sufficient	NULL
to	NULL
mediate	NULL
an	NULL
increase	NULL
in	NULL
transcriptional	NULL
activity	NULL
,	NULL
although	NULL
the	NULL
magnitude	NULL
of	NULL
this	NULL
increase	NULL
was	NULL
less	NULL
than	NULL
those	NULL
mediated	NULL
by	NULL
longer	NULL
constructs	NULL
.	NULL

For	NULL
all	NULL
constructs	NULL
,	NULL
luciferase	NULL
activity	NULL
increased	NULL
with	NULL
the	NULL
concentration	NULL
of	NULL
pSAP2	NULL
in	NULL
the	NULL
range	NULL
of	NULL
0-2	NULL
ug	NULL
.	NULL

With	NULL
higher	NULL
amounts	NULL
,	NULL
however	NULL
,	NULL
luciferase	NULL
activity	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
176	NULL
AP-2	NULL
Binding	NULL
Sites	NULL
Regulate	NULL
V-ATPase	NULL
B2	NULL
Subunit	NULL
Expression	NULL
Sp1	NULL
I	NULL
ME	NULL
!	NULL

SBM	NULL
|	NULL
no	NULL
protein	NULL
.	NULL

AP2	NULL
J	NULL
+12	NULL
to	NULL
+20	NULL
(	NULL
8	NULL
)	NULL
+3	NULL
to	NULL
+11	NULL
(	NULL
7	NULL
)	NULL
1	NULL
-28	NULL
to	NULL
-20	NULL
(	NULL
6	NULL
)	NULL
1	NULL
-67	NULL
to	NULL
-59	NULL
(	NULL
§	NULL
)	NULL
83	NULL
to	NULL
-70	NULL
|	NULL
:	NULL
-79	NULL
to	NULL
-71	NULL
(	NULL
4	NULL
)	NULL
J	NULL
107	NULL
to	NULL
-99	NULL
(	NULL
3	NULL
)	NULL
116	NULL
to	NULL
103	NULL
:	NULL
|	NULL
127	NULL
to	NULL
119	NULL
(	NULL
2	NULL
)	NULL
®	NULL
}	NULL
167	NULL
to	NULL
159	NULL
(	NULL
1	NULL
)	NULL
-	NULL
am	NULL
an	NULL
tin	NULL
tite	NULL
~*	NULL
«	NULL
won	NULL
aime	NULL
<	NULL
--	NULL
transcriptional	NULL
start	NULL
``	NULL
dts	NULL
(	NULL
-207	NULL
)	NULL
te	NULL
«	NULL
m	NULL
__	NULL
.	NULL

ate	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
5	NULL
'	NULL
-untranslated	NULL
region	NULL
of	NULL
the	NULL
B2	NULL
gene	NULL
.	NULL

A	NULL
DNA	NULL
probe	NULL
spanning	NULL
the	NULL
entire	NULL
5'-untranslated	NULL
region	NULL
(	NULL
-207	NULL
to	NULL
-1	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
purified	NULL
Spl	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
AP-2	NULL
@	NULL
«	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
,	NULL
and	NULL
separated	NULL
by	NULL
electrophoresis	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

A	NULL
total	NULL
of	NULL
eight	NULL
AP-2	NULL
binding	NULL
sites	NULL
and	NULL
two	NULL
Spl	NULL
binding	NULL
sites	NULL
were	NULL
identified	NULL
.	NULL

(	NULL
1	NULL
)	NULL
-207	NULL
GCCTCCCAGCACGECTGETCAGCTCCTCTTGCTCGCAAGCAGGTCTCEECCC	NULL
(	NULL
2	NULL
)	NULL
~157	NULL
CAGCGECECGAAGTCACCAGECTGSGEGCGGCCGeCeqccaacesceecee	NULL
(	NULL
3	NULL
)	NULL
(	NULL
4	NULL
)	NULL
(	NULL
5	NULL
)	NULL
=107	NULL
GGCGAGGCCECGCECCGCASCECGCATACECEGAGCCTCCGCCGCGcecc	NULL
(	NULL
6	NULL
)	NULL
-57	NULL
GCCTTGGTATATCTGCETGCGCGCGTCTGCTGEGCCAGTCEEGACACAGG	NULL
+1	NULL
(	NULL
7	NULL
)	NULL
(	NULL
8	NULL
)	NULL
-7	NULL
AGACAACATGGCGCTGCGGGCGATGCGSGGGATTCTCAACGGGGCCGCAC	NULL
+44	NULL
CCGAGCTACCCGTCCCCACCGETESCCCECCGGTGCCAGCTCCGCGAGCAC	NULL
+94	NULL
GCGCTGGCAGTCAGTCGGAACTACCTCTCCCASCCTCGCCTCA	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

AP-2	NULL
and	NULL
Spl	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
V-ATPase	NULL
B2	NULL
gene	NULL
.	NULL

The	NULL
AP-2	NULL
binding	NULL
sites	NULL
are	NULL
underlined	NULL
and	NULL
numbered	NULL
in	NULL
accordance	NULL
with	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Spl	NULL
binding	NULL
sites	NULL
(	NULL
GC	NULL
boxes	NULL
)	NULL
are	NULL
in	NULL
bold	NULL
.	NULL

type	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
was	NULL
reported	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

began	NULL
to	NULL
decrease	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
self-interfer-ence	NULL
of	NULL
AP-2	NULL
transcriptional	NULL
activation	NULL
as	NULL
described	NULL
by	NULL
Kannan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
85	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
exogenous	NULL
AP-2	NULL
«	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
LLC-PK	NULL
,	NULL
(	NULL
a	NULL
porcine	NULL
kidney	NULL
proximal	NULL
tubule	NULL
line	NULL
)	NULL
,	NULL
293	NULL
(	NULL
a	NULL
human	NULL
embryonic	NULL
kidney	NULL
fibroblast	NULL
line	NULL
)	NULL
,	NULL
and	NULL
HepG2	NULL
(	NULL
a	NULL
human	NULL
hepa-toma	NULL
line	NULL
)	NULL
also	NULL
resulted	NULL
in	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
B2	NULL
promoter	NULL
,	NULL
but	NULL
higher	NULL
concentrations	NULL
of	NULL
pSAP-2	NULL
plasmid	NULL
were	NULL
required	NULL
for	NULL
promoter	NULL
activation	NULL
in	NULL
293	NULL
and	NULL
HepG2	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
AP-2	NULL
«	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
transcription	NULL
from	NULL
the	NULL
V-ATPase	NULL
B2	NULL
promoter	NULL
in	NULL
multiple	NULL
cell	NULL
lines	NULL
.	NULL

AP-2	NULL
Binding	NULL
Sites	NULL
Are	NULL
Required	NULL
for	NULL
Activation	NULL
of	NULL
the	NULL
B2	NULL
Promoter	NULL
during	NULL
Monocyte-Macrophage	NULL
Differentiation-In	NULL
a	NULL
prior	NULL
study	NULL
(	NULL
18	NULL
)	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
sequences	NULL
in	NULL
the	NULL
region	NULL
be	NULL
6.00	NULL
RRB	NULL
-~317	NULL
to	NULL
+	NULL
30	NULL
(	NULL
8	NULL
sites	NULL
)	NULL
1	NULL
-317	NULL
to	NULL
-52	NULL
(	NULL
5	NULL
sites	NULL
)	NULL
L-	NULL
]	NULL
-317	NULL
to	NULL
-124	NULL
(	NULL
1	NULL
site	NULL
)	NULL
EEN	NULL
-317	NULL
to	NULL
-199	NULL
(	NULL
0	NULL
sites	NULL
)	NULL
EG	NULL
-317	NULL
to	NULL
-124	NULL
mut	NULL
(	NULL
0	NULL
sites	NULL
)	NULL
&	NULL
o	NULL
=	NULL
]	NULL
1	NULL
br	NULL
o	NULL
5	NULL
1	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
s	NULL
=	NULL
$	NULL
1	NULL
|	NULL
-_	NULL
o	NULL
o	NULL
I	NULL
0.0	NULL
ug	NULL
Amount	NULL
of	NULL
pSAP2	NULL
DNA	NULL
Added	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
B2	NULL
promoter	NULL
by	NULL
AP-2	NULL
@	NULL
.	NULL

Fragments	NULL
of	NULL
the	NULL
B2	NULL
promoter	NULL
containing	NULL
indicated	NULL
numbers	NULL
of	NULL
AP-2	NULL
binding	NULL
sites	NULL
were	NULL
ligated	NULL
to	NULL
the	NULL
5	NULL
end	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
cDNA	NULL
.	NULL

The	NULL
constructs	NULL
were	NULL
co-transfected	NULL
into	NULL
THP-1	NULL
monocytes	NULL
with	NULL
varying	NULL
amounts	NULL
of	NULL
the	NULL
AP-2	NULL
«	NULL
expression	NULL
vector	NULL
pSAP2	NULL
as	NULL
shown	NULL
,	NULL
and	NULL
with	NULL
the	NULL
plasmid	NULL
pRSVcat	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Activity	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
luciferase	NULL
activity	NULL
to	NULL
CAT	NULL
activity	NULL
.	NULL

At	NULL
least	NULL
four	NULL
independent	NULL
experiments	NULL
were	NULL
performed	NULL
for	NULL
each	NULL
construct	NULL
.	NULL

-2.4	NULL
kb	NULL
to	NULL
-96	NULL
[	NULL
/	NULL
(	NULL
6	NULL
)	NULL
-728	NULL
to	NULL
-96	NULL
(	NULL
3	NULL
)	NULL
(	NULL
5	NULL
)	NULL
-317	NULL
to	NULL
-96	NULL
-274	NULL
to	NULL
-96	NULL
7/	NULL
,	NULL
(	NULL
6	NULL
)	NULL
-274	NULL
to	NULL
~124	NULL
(	NULL
6	NULL
)	NULL
Promoter	NULL
Construct	NULL
-274	NULL
to	NULL
-199	NULL
(	NULL
7	NULL
)	NULL
-317	NULL
to	NULL
-124	NULL
mut	NULL
{	NULL
1	NULL
0	NULL
100	NULL
200	NULL
300	NULL
400	NULL
Induction	NULL
Following	NULL
TPA	NULL
Treatment	NULL
(	NULL
%	NULL
of	NULL
Control	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
5'-untranslated	NULL
region	NULL
of	NULL
the	NULL
B2	NULL
gene	NULL
.	NULL

Luciferase	NULL
reporter	NULL
constructs	NULL
containing	NULL
the	NULL
indicated	NULL
fragments	NULL
of	NULL
the	NULL
B2	NULL
promoter	NULL
were	NULL
transfected	NULL
into	NULL
THP-1	NULL
monocytes	NULL
.	NULL

After	NULL
2	NULL
days	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
divided	NULL
and	NULL
incubated	NULL
an	NULL
additional	NULL
5	NULL
h	NULL
with	NULL
and	NULL
without	NULL
160	NULL
nM	NULL
TPA	NULL
.	NULL

Bars	NULL
(	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL
)	NULL

represent	NULL
the	NULL
luciferase	NULL
activity	NULL
in	NULL
TPA-treated	NULL
cells	NULL
expressed	NULL
as	NULL
a	NULL
percent	NULL
of	NULL
activity	NULL
in	NULL
the	NULL
control	NULL
undifferentiated	NULL
cells	NULL
.	NULL

Data	NULL
from	NULL
the	NULL
top	NULL
four	NULL
constructs	NULL
and	NULL
from	NULL
promoter	NULL
fragment	NULL
-274	NULL
to	NULL
-199	NULL
were	NULL
reported	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
and	NULL
are	NULL
shown	NULL
for	NULL
comparison	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.002	NULL
.	NULL

The	NULL
number	NULL
of	NULL
independent	NULL
trials	NULL
for	NULL
each	NULL
construct	NULL
is	NULL
shown	NULL
in	NULL
parentheses	NULL
.	NULL

tween	NULL
-96	NULL
and	NULL
-199	NULL
,	NULL
containing	NULL
three	NULL
AP-2	NULL
binding	NULL
sites	NULL
,	NULL
were	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
from	NULL
the	NULL
B2	NULL
promoter	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

To	NULL
delineate	NULL
further	NULL
the	NULL
segment	NULL
of	NULL
the	NULL
gene	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
analysis	NULL
of	NULL
additional	NULL
deletions	NULL
in	NULL
this	NULL
region	NULL
.	NULL

A	NULL
luciferase	NULL
construct	NULL
was	NULL
created	NULL
with	NULL
promoter	NULL
sequences	NULL
from	NULL
-274	NULL
to	NULL
-124	NULL
(	NULL
containing	NULL
only	NULL
AP-2	NULL
site	NULL
1	NULL
)	NULL
and	NULL
tested	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
enhance	NULL
transcription	NULL
during	NULL
monocyte-macrophage	NULL
differentiation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
magnitude	NULL
of	NULL
activation	NULL
with	NULL
the	NULL
-274	NULL
to	NULL
-124	NULL
construct	NULL
,	NULL
although	NULL
it	NULL
did	NULL
not	NULL
achieve	NULL
statistical	NULL
significance	NULL
(	NULL
p	NULL
=	NULL
0.053	NULL
)	NULL
,	NULL
was	NULL
less	NULL
than	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
AP-2	NULL
Binding	NULL
Sites	NULL
Regulate	NULL
V-ATPase	NULL
B2	NULL
Subunit	NULL
Expression	NULL
177	NULL
A	NULL
LANE	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
I	NULL
i	NULL
a	NULL
-|	NULL
--	NULL
I	NULL
I	NULL
I	NULL
I	NULL
Extracts	NULL
[	NULL
THP-	NULL
‘	NULL
I	NULL
monocyte	NULL
:	NULL
THP-1	NULL
macrophage	NULL
:	NULL
Site	NULL
1	NULL
:	NULL
-	NULL
-f-	NULL
-	NULL
-f	NULL
-=-HMtlla	NULL
:	NULL
--	NULL
-f	NULL
-	NULL
-	NULL
-f	NULL
-=-Sp1	NULL
:	NULL
wa	NULL
wo	NULL
su	NULL
so	NULL
afe	NULL
so	NULL
s	NULL
_	NULL
<	NULL
fe	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Competitive	NULL
Oligonucleotides	NULL
LANE	NULL
B	NULL
c	NULL
c	NULL
THP-1	NULL
monocyte	NULL
ext	NULL
.	NULL

:	NULL
--	NULL
of	NULL
o	NULL
<	NULL
foo-	NULL
<	NULL
~	NULL
THP-1	NULL
macrophage	NULL
ext	NULL
.	NULL

:	NULL
=	NULL
=	NULL
=	NULL
p	NULL
4+	NULL
=-Recombinant	NULL
Sp1	NULL
:	NULL
wo	NULL
ec	NULL
&	NULL
--	NULL
f	NULL
Sp1	NULL
oligo	NULL
competition	NULL
:	NULL
-	NULL
<	NULL
-	NULL
0	NULL
<	NULL
&	NULL
«	NULL
fo	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Mobility	NULL
shift	NULL
analysis	NULL
of	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
probed	NULL
with	NULL
B2	NULL
promoter	NULL
AP-2	NULL
site	NULL
1	NULL
oligonucleotide	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
control	NULL
THP-1	NULL
cells	NULL
(	NULL
monocytes	NULL
,	NULL
Zanes	NULL
2-5	NULL
)	NULL
or	NULL
TPA-treated	NULL
cells	NULL
(	NULL
macrophages	NULL
,	NULL
lanes	NULL
6-9	NULL
)	NULL
analyzed	NULL
for	NULL
protein-DNA	NULL
complex	NULL
formation	NULL
using	NULL
labeled	NULL
double-stranded	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
AP-2	NULL
binding	NULL
site	NULL
1	NULL
of	NULL
the	NULL
B2	NULL
promoter	NULL
.	NULL

Unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
50-fold	NULL
excess	NULL
over	NULL
labeled	NULL
probe	NULL
)	NULL
were	NULL
added	NULL
to	NULL
mixtures	NULL
to	NULL
determine	NULL
specificity	NULL
of	NULL
binding	NULL
:	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
,	NULL
competition	NULL
with	NULL
unlabeled	NULL
site	NULL
1	NULL
probe	NULL
;	NULL
Zanes	NULL
4	NULL
and	NULL
8	NULL
competition	NULL
with	NULL
the	NULL
AP-2	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
human	NULL
metallothionein	NULL
IIa	NULL
basal	NULL
level	NULL
element	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
9	NULL
,	NULL
competition	NULL
with	NULL
an	NULL
Spl	NULL
binding	NULL
site	NULL
probe	NULL
(	NULL
GC	NULL
box	NULL
)	NULL
,	NULL
demonstrating	NULL
lack	NULL
of	NULL
competitive	NULL
binding	NULL
to	NULL
the	NULL
THP-1	NULL
cell	NULL
nuclear	NULL
factor	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
monocytes	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
macrophages	NULL
(	NULL
Zanes	NULL
those	NULL
mediated	NULL
by	NULL
longer	NULL
constructs	NULL
,	NULL
a	NULL
result	NULL
similar	NULL
to	NULL
that	NULL
obtained	NULL
by	NULL
coexpression	NULL
of	NULL
exogenous	NULL
AP-2	NULL
with	NULL
this	NULL
promoter	NULL
fragment	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
site	NULL
1	NULL
,	NULL
or	NULL
surrounding	NULL
sequences	NULL
,	NULL
accounts	NULL
for	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
transcriptional	NULL
response	NULL
to	NULL
a	NULL
differentiation	NULL
stimulus	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
deletion	NULL
of	NULL
site	NULL
1	NULL
abolished	NULL
transcriptional	NULL
activation	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
construct	NULL
-317	NULL
to	NULL
-124mut	NULL
,	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
site	NULL
1	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
)	NULL
,	NULL
to	NULL
enhance	NULL
transcription	NULL
during	NULL
monocyte-macrophage	NULL
differentiation	NULL
.	NULL

In	NULL
THP-1	NULL
monocytes	NULL
transfected	NULL
with	NULL
this	NULL
construct	NULL
,	NULL
no	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
was	NULL
observed	NULL
following	NULL
phorbol	NULL
ester	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
AP-2	NULL
binding	NULL
sites	NULL
have	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
induction	NULL
of	NULL
B2	NULL
expression	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

A	NULL
Monocytic	NULL
Nuclear	NULL
Protein	NULL
Binds	NULL
to	NULL
AP-2	NULL
Consensus	NULL
Se-quences-To	NULL
identify	NULL
monocytic	NULL
nuclear	NULL
proteins	NULL
capable	NULL
of	NULL
binding	NULL
AP-2	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
undifferentiated	NULL
or	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
both	NULL
THP-1	NULL
monocytes	NULL
and	NULL
THP-1	NULL
macrophages	NULL
contained	NULL
a	NULL
protein	NULL
that	NULL
bound	NULL
to	NULL
radiolabeled	NULL
oligonucleotides	NULL
containing	NULL
AP-2	NULL
binding	NULL
site	NULL
1	NULL
from	NULL
the	NULL
B2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Binding	NULL
specificity	NULL
was	NULL
demonstrated	NULL
by	NULL
addition	NULL
of	NULL
either	NULL
unlabeled	NULL
probe	NULL
or	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
different	NULL
AP-2	NULL
binding	NULL
site	NULL
(	NULL
from	NULL
the	NULL
human	NULL
metallothionein	NULL
IIa	NULL
basal	NULL
level	NULL
element	NULL
(	NULL
28	NULL
)	NULL
)	NULL
,	NULL
which	NULL
abolished	NULL
binding	NULL
of	NULL
the	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
labeled	NULL
probe	NULL
;	NULL
addition	NULL
of	NULL
an	NULL
irrelevant	NULL
oligonucleotide	NULL
,	NULL
however	NULL
(	NULL
in	NULL
this	NULL
case	NULL
,	NULL
the	NULL
binding	NULL
sequence	NULL
for	NULL
Spl	NULL
,	NULL
another	NULL
G	NULL
+	NULL
C-rich	NULL
sequence	NULL
)	NULL
,	NULL
did	NULL
not	NULL
abolish	NULL
binding	NULL
of	NULL
the	NULL
proteins	NULL
to	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
site	NULL
1	NULL
oligonucleotide	NULL
bound	NULL
by	NULL
nuclear	NULL
extract	NULL
was	NULL
increased	NULL
in	NULL
THP-1	NULL
macrophages	NULL
compared	NULL
with	NULL
THP-1	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
apparent	NULL
increase	NULL
in	NULL
the	NULL
AP-2-like	NULL
factor	NULL
in	NULL
THP-1	NULL
macrophages	NULL
was	NULL
due	NULL
to	NULL
a	NULL
more	NULL
efficient	NULL
extract	NULL
preparation	NULL
,	NULL
we	NULL
assayed	NULL
the	NULL
same	NULL
extracts	NULL
for	NULL
Spl	NULL
binding	NULL
proteins	NULL
.	NULL

Studies	NULL
in	NULL
U-937	NULL
cells	NULL
,	NULL
another	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
Spl	NULL
content	NULL
of	NULL
monocytes	NULL
does	NULL
not	NULL
change	NULL
significantly	NULL
during	NULL
TPA-induced	NULL
differentiation	NULL
into	NULL
macrophages	NULL
(	NULL
36	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
Spl	NULL
content	NULL
of	NULL
THP-1	NULL
cell	NULL
nuclear	NULL
extract	NULL
preparations	NULL
exhibited	NULL
a	NULL
minor	NULL
decrease	NULL
during	NULL
differentiation	NULL
to	NULL
macrophages	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
greater	NULL
recovery	NULL
of	NULL
transcription	NULL
factors	NULL
was	NULL
not	NULL
the	NULL
reason	NULL
for	NULL
the	NULL
increase	NULL
in	NULL
AP-2-like	NULL
factor	NULL
binding	NULL
.	NULL

The	NULL
basis	NULL
for	NULL
the	NULL
slight	NULL
decrease	NULL
in	NULL
the	NULL
Spl	NULL
content	NULL
of	NULL
THP-1	NULL
cell	NULL
nuclear	NULL
extract	NULL
is	NULL
unclear	NULL
but	NULL
may	NULL
have	NULL
caused	NULL
underestima-tion	NULL
of	NULL
the	NULL
increase	NULL
in	NULL
AP-2-like	NULL
factor	NULL
binding	NULL
.	NULL

We	NULL
next	NULL
incubated	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
,	NULL
or	NULL
purified	NULL
AP-2a	NULL
,	NULL
with	NULL
oligonucleotides	NULL
containing	NULL
different	NULL
AP-2	NULL
binding	NULL
sequences	NULL
to	NULL
determine	NULL
whether	NULL
any	NULL
differences	NULL
in	NULL
binding	NULL
affinity	NULL
existed	NULL
among	NULL
several	NULL
sequences	NULL
of	NULL
DNA	NULL
capable	NULL
of	NULL
binding	NULL
AP-2	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
probes	NULL
included	NULL
the	NULL
following	NULL
:	NULL
1	NULL
)	NULL
a	NULL
commercially	NULL
available	NULL
AP-2	NULL
binding	NULL
sequence	NULL
(	NULL
Promega	NULL
)	NULL
from	NULL
the	NULL
human	NULL
metallothionein	NULL
IIa	NULL
distal	NULL
basal	NULL
level	NULL
element	NULL
(	NULL
hMtlla	NULL
BLE	NULL
;	NULL
(	NULL
28	NULL
)	NULL
)	NULL
;	NULL
2	NULL
)	NULL
the	NULL
B2	NULL
promoter	NULL
AP-2	NULL
binding	NULL
site	NULL
1	NULL
;	NULL
and	NULL
3	NULL
)	NULL
the	NULL
B2	NULL
promoter	NULL
AP-2	NULL
binding	NULL
site	NULL
5	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
illustrates	NULL
two	NULL
significant	NULL
differences	NULL
between	NULL
the	NULL
THP-1	NULL
factor	NULL
and	NULL
recombinant	NULL
AP-2	NULL
«	NULL
.	NULL

First	NULL
,	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
THP-1	NULL
factor	NULL
was	NULL
consistently	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
AP-2	NULL
«	NULL
under	NULL
the	NULL
assay	NULL
conditions	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
THP-1	NULL
factor	NULL
and	NULL
recombinant	NULL
4	NULL
and	NULL
5	NULL
)	NULL
were	NULL
analyzed	NULL
for	NULL
binding	NULL
to	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
an	NULL
Spl	NULL
binding	NULL
site	NULL
.	NULL

Lanes	NULL
3	NULL
and	NULL
5	NULL
,	NULL
competition	NULL
with	NULL
unlabeled	NULL
probe	NULL
;	NULL
Zane	NULL
6	NULL
,	NULL
binding	NULL
of	NULL
probe	NULL
to	NULL
recombinant	NULL
Spl	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
(	NULL
lames	NULL
2-5	NULL
)	NULL
produced	NULL
protein-DNA	NULL
complexes	NULL
with	NULL
different	NULL
mobilities	NULL
,	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
different	NULL
post-translation	NULL
modifications	NULL
of	NULL
Spl	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.t	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
178	NULL
AP-2	NULL
Binding	NULL
Sites	NULL
Regulate	NULL
V-ATPase	NULL
B2	NULL
Subunit	NULL
Expression	NULL
LANES	NULL
1	NULL
2	NULL
3	NULL
4	NULL
§	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
THP-1	NULL
-TPA	NULL
:	NULL
++—	NULL
--	NULL
++	NULL
--	NULL
-++	NULL
--	NULL
-THP-1	NULL
+TPA	NULL
:	NULL
-	NULL
-	NULL
<	NULL
-	NULL
-	NULL
-of	NULL
f	NULL
4	NULL
-	NULL
-	NULL
fp	NULL
f	NULL
Recomb	NULL
.	NULL

AP-2	NULL
:	NULL
we	NULL
me	NULL
a	NULL
ee	NULL
afe	NULL
ee	NULL
oe	NULL
ee	NULL
e	NULL
afe	NULL
e	NULL
e	NULL
e	NULL
e	NULL
afe	NULL
Competitor	NULL
oligo	NULL
:	NULL
-	NULL
|f	NULL
-	NULL
f-	NULL
~	NULL
f	NULL
-f-	NULL
_-	NULL
f	NULL
-f	NULL
R	NULL
|	NULL
II	NULL
_	NULL
Probes	NULL
:	NULL
hMtlIA	NULL
B2	NULL
site	NULL
1	NULL
B2	NULL
site	NULL
5	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

AP-2	NULL
and	NULL
the	NULL
THP-1	NULL
nuclear	NULL
factor	NULL
exhibit	NULL
differences	NULL
in	NULL
affinity	NULL
among	NULL
several	NULL
AP-2	NULL
binding	NULL
site	NULL
oligonucleotides	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
monocytes	NULL
or	NULL
macrophages	NULL
were	NULL
probed	NULL
with	NULL
double-stranded	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
AP-2	NULL
binding	NULL
sites	NULL
from	NULL
the	NULL
human	NULL
metallothionein	NULL
IIa	NULL
basal	NULL
level	NULL
element	NULL
or	NULL
to	NULL
the	NULL
indicated	NULL
B2	NULL
promoter	NULL
AP-2	NULL
binding	NULL
sites	NULL
.	NULL

For	NULL
each	NULL
probe	NULL
,	NULL
the	NULL
lanes	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
lane	NULL
1	NULL
,	NULL
THP-1	NULL
monocyte	NULL
extract	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
THP-1	NULL
monocyte	NULL
extract	NULL
with	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
as	NULL
competitor	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
THP-1	NULL
macrophage	NULL
extract	NULL
;	NULL
lame	NULL
4	NULL
,	NULL
THP-1	NULL
macrophage	NULL
extract	NULL
with	NULL
unlabeled	NULL
probe	NULL
as	NULL
competitor	NULL
;	NULL
and	NULL
Zane	NULL
5	NULL
,	NULL
recombinant	NULL
AP-2	NULL
«	NULL
(	NULL
40	NULL
nM	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
from	NULL
THP-1	NULL
cell	NULL
extracts	NULL
.	NULL

Separate	NULL
experiments	NULL
,	NULL
using	NULL
less	NULL
recombinant	NULL
AP-2	NULL
@	NULL
,	NULL
confirmed	NULL
that	NULL
only	NULL
a	NULL
single	NULL
protein-DNA	NULL
complex	NULL
was	NULL
formed	NULL
with	NULL
the	NULL
hMtlla	NULL
probe	NULL
,	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
the	NULL
complex	NULL
in	NULL
lane	NULL
5	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

AP-2a	NULL
«	NULL
exhibited	NULL
different	NULL
relative	NULL
affinities	NULL
for	NULL
the	NULL
probes	NULL
tested	NULL
.	NULL

The	NULL
hMtlla	NULL
BLE	NULL
site	NULL
oligonucleotide	NULL
bound	NULL
strongly	NULL
to	NULL
recombinant	NULL
AP-2	NULL
«	NULL
@	NULL
,	NULL
forming	NULL
a	NULL
single	NULL
protein-DNA	NULL
complex	NULL
.	NULL

When	NULL
incubated	NULL
with	NULL
THP-1	NULL
extracts	NULL
,	NULL
the	NULL
hMtlla	NULL
BLE	NULL
site	NULL
oligonucleotide	NULL
formed	NULL
multiple	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
B2	NULL
site	NULL
1	NULL
and	NULL
5	NULL
oligonucleotide	NULL
probes	NULL
formed	NULL
a	NULL
single	NULL
predominant	NULL
protein-DNA	NULL
complex	NULL
in	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
and	NULL
bound	NULL
to	NULL
recombinant	NULL
AP-2	NULL
«	NULL
weakly	NULL
in	NULL
comparison	NULL
to	NULL
the	NULL
hMtlla	NULL
probe	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
THP-1	NULL
factor	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
below	NULL
)	NULL
showed	NULL
the	NULL
concentration	NULL
of	NULL
this	NULL
DNA-binding	NULL
protein	NULL
to	NULL
be	NULL
several	NULL
hundred-fold	NULL
less	NULL
than	NULL
that	NULL
of	NULL
AP-2	NULL
«	NULL
in	NULL
the	NULL
reactions	NULL
.	NULL

A	NULL
second	NULL
protein-DNA	NULL
complex	NULL
that	NULL
migrated	NULL
slightly	NULL
ahead	NULL
of	NULL
the	NULL
predominant	NULL
complex	NULL
was	NULL
found	NULL
occasionally	NULL
in	NULL
THP-1	NULL
extract	NULL
preparations	NULL
in	NULL
some	NULL
experiments	NULL
(	NULL
see	NULL
site	NULL
1	NULL
probe	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

This	NULL
protein-DNA	NULL
complex	NULL
was	NULL
not	NULL
observed	NULL
reproducibly	NULL
and	NULL
may	NULL
represent	NULL
a	NULL
degradation	NULL
product	NULL
of	NULL
the	NULL
intact	NULL
transcription	NULL
factor	NULL
.	NULL

Although	NULL
we	NULL
found	NULL
that	NULL
site	NULL
1	NULL
bound	NULL
to	NULL
purified	NULL
AP-2	NULL
«	NULL
in	NULL
DNase	NULL
I	NULL
footprinting	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
,	NULL
in	NULL
repeated	NULL
experiments	NULL
,	NULL
to	NULL
detect	NULL
any	NULL
protein-DNA	NULL
complex	NULL
formation	NULL
between	NULL
site	NULL
1	NULL
and	NULL
purified	NULL
AP-2	NULL
«	NULL
in	NULL
the	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

We	NULL
were	NULL
able	NULL
,	NULL
however	NULL
,	NULL
to	NULL
inhibit	NULL
completely	NULL
binding	NULL
of	NULL
recombinant	NULL
AP-2	NULL
«	NULL
to	NULL
the	NULL
hMtlla	NULL
BLE	NULL
site	NULL
by	NULL
preincubating	NULL
the	NULL
factor	NULL
with	NULL
a	NULL
>	NULL
5000-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
site	NULL
1	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
THP-1	NULL
factor	NULL
in	NULL
these	NULL
assays	NULL
with	NULL
that	NULL
of	NULL
AP-2	NULL
«	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
THP-1	NULL
factor	NULL
using	NULL
the	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

A	NULL
constant	NULL
A	NULL
Amount	NULL
of	NULL
probe	NULL
added	NULL
0.04	NULL
nM	NULL
0.09	NULL
nM	NULL
0.19	NULL
nM	NULL
0.38	NULL
nM	NULL
0.75	NULL
nM	NULL
1.50	NULL
nM	NULL
3.00	NULL
nM	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
THP-1	NULL
factor	NULL
by	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

A	NULL
,	NULL
increasing	NULL
amounts	NULL
of	NULL
radiolabeled	NULL
site	NULL
5	NULL
probe	NULL
were	NULL
allowed	NULL
to	NULL
bind	NULL
with	NULL
1	NULL
ul	NULL
of	NULL
THP-1	NULL
monocyte	NULL
extract	NULL
in	NULL
a	NULL
10-pl	NULL
reaction	NULL
until	NULL
saturation	NULL
of	NULL
the	NULL
THP-1	NULL
factor	NULL
was	NULL
reached	NULL
(	NULL
Zanes	NULL
marked	NULL
by	NULL
asterisks	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
factor-DNA	NULL
complex	NULL
at	NULL
saturation	NULL
was	NULL
compared	NULL
with	NULL
a	NULL
standard	NULL
curve	NULL
of	NULL
free	NULL
site	NULL
5	NULL
probe	NULL
at	NULL
a	NULL
known	NULL
specific	NULL
activity	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
probe	NULL
bound	NULL
in	NULL
the	NULL
saturated	NULL
factor-DNA	NULL
complexes	NULL
was	NULL
calculated	NULL
at	NULL
0.12	NULL
nM	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
THP-1	NULL
factor	NULL
of	NULL
interest	NULL
is	NULL
marked	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

amount	NULL
of	NULL
THP-1	NULL
monocyte	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
radiolabeled	NULL
site	NULL
5	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
protein-DNA	NULL
complex	NULL
formed	NULL
was	NULL
assayed	NULL
,	NULL
allowing	NULL
the	NULL
number	NULL
of	NULL
moles	NULL
of	NULL
probe	NULL
bound	NULL
to	NULL
be	NULL
determined	NULL
when	NULL
all	NULL
of	NULL
the	NULL
available	NULL
THP-1	NULL
factor	NULL
was	NULL
complexed	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
factor-DNA	NULL
complex	NULL
at	NULL
saturation	NULL
was	NULL
compared	NULL
with	NULL
a	NULL
standard	NULL
curve	NULL
of	NULL
free	NULL
probe	NULL
of	NULL
known	NULL
specific	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Assuming	NULL
a	NULL
1:1	NULL
molar	NULL
ratio	NULL
of	NULL
factor	NULL
to	NULL
DNA	NULL
in	NULL
the	NULL
complex	NULL
,	NULL
we	NULL
estimated	NULL
the	NULL
concentration	NULL
of	NULL
THP-1	NULL
monocyte	NULL
factor	NULL
in	NULL
our	NULL
standard	NULL
DNA-binding	NULL
reactions	NULL
(	NULL
Fe	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
)	NULL
to	NULL
be	NULL
0.12	NULL
nm	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
recombinant	NULL
AP-2	NULL
«	NULL
in	NULL
the	NULL
reactions	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
was	NULL
40	NULL
nm	NULL
.	NULL

Thus	NULL
,	NULL
even	NULL
at	NULL
a	NULL
concentration	NULL
330-fold	NULL
greater	NULL
than	NULL
the	NULL
THP-1	NULL
factor	NULL
,	NULL
AP-2	NULL
«	NULL
bound	NULL
to	NULL
the	NULL
site	NULL
1	NULL
and	NULL
5	NULL
probes	NULL
only	NULL
weakly	NULL
.	NULL

Both	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
affinity	NULL
of	NULL
AP-2	NULL
«	NULL
and	NULL
the	NULL
THP-1	NULL
factor	NULL
for	NULL
different	NULL
probes	NULL
,	NULL
and	NULL
the	NULL
differences	NULL
in	NULL
mobility	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
,	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
two	NULL
proteins	NULL
are	NULL
distinct	NULL
.	NULL

As	NULL
an	NULL
additional	NULL
and	NULL
independent	NULL
method	NULL
for	NULL
determining	NULL
whether	NULL
the	NULL
THP-1	NULL
nuclear	NULL
factor	NULL
was	NULL
different	NULL
from	NULL
AP-2	NULL
«	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
using	NULL
the	NULL
antibody	NULL
``	NULL
su-pershift	NULL
``	NULL
method	NULL
(	NULL
37	NULL
)	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
factor	NULL
is	NULL
im-munologically	NULL
similar	NULL
to	NULL
AP-2	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Antibody	NULL
to	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
human	NULL
AP-2	NULL
«	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
incubated	NULL
with	NULL
nuclear	NULL
proteins	NULL
prior	NULL
to	NULL
probe	NULL
addition	NULL
and	NULL
elec-trophoresis	NULL
,	NULL
did	NULL
not	NULL
produce	NULL
a	NULL
mobility	NULL
supershift	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
from	NULL
THP-1	NULL
cells	NULL
(	NULL
from	NULL
either	NULL
the	NULL
monocytic	NULL
or	NULL
macrophage-like	NULL
forms	NULL
)	NULL
,	NULL
but	NULL
the	NULL
antibody	NULL
shifted	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
entire	NULL
AP-2	NULL
«	NULL
-oligonucleotide	NULL
complex	NULL
.	NULL

Although	NULL
the	NULL
antibody	NULL
was	NULL
not	NULL
tested	NULL
directly	NULL
in	NULL
supershift	NULL
assays	NULL
for	NULL
binding	NULL
to	NULL
AP-2	NULL
$	NULL
,	NULL
it	NULL
does	NULL
detect	NULL
on	NULL
immunoblots	NULL
and	NULL
should	NULL
have	NULL
caused	NULL
a	NULL
mobility	NULL
supershift	NULL
if	NULL
the	NULL
THP-1	NULL
factor	NULL
were	NULL
AP-28B	NULL
(	NULL
27	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
other	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
have	NULL
an	NULL
AP-2	NULL
site-binding	NULL
protein	NULL
with	NULL
properties	NULL
similar	NULL
to	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
AP-2	NULL
Binding	NULL
Sites	NULL
Regulate	NULL
V-ATPase	NULL
B2	NULL
Subunit	NULL
Expression	NULL
179	NULL
LANE	NULL
1002	NULL
3	NULL
4	NULL
50	NULL
60	NULL
To	NULL
8s	NULL
9	NULL
THP	NULL
:	NULL
-	NULL
=p	NULL
fo-	NULL
<	NULL
-	NULL
<	NULL
-	NULL
-	NULL
-	NULL
THPA	NULL
+TPA	NULL
:	NULL
|	NULL
-	NULL
-	NULL
-~	NULL
op	NULL
«	NULL
fo	NULL
_	NULL
_	NULL
U-937	NULL
:	NULL
_____++__	NULL
Recomb	NULL
.	NULL

AP-2	NULL
:	NULL
=	NULL
=	NULL
=	NULL
-~	NULL
-=	NULL
._	NULL
+	NULL
--	NULL
-	NULL
Anti-AP-2	NULL
Ab	NULL
:	NULL
_-	NULL
_	NULL
.	NULL

-	NULL
=f	NULL
-	NULL
fo-	NULL
-f	NULL
-	NULL
&	NULL
-a	NULL
4	NULL
-	NULL
-	NULL
-Y	NULL
~~	NULL
mA	NULL
_	NULL
~-uwllp	NULL
'If	NULL
T	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Supershift	NULL
analysis	NULL
of	NULL
THP-1	NULL
and	NULL
U-987	NULL
nuclear	NULL
proteins	NULL
.	NULL

Mobility	NULL
shift	NULL
and	NULL
antibody	NULL
supershift	NULL
analyses	NULL
were	NULL
performed	NULL
on	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
monocytes	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
THP-1	NULL
macrophages	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
U-987	NULL
promonocytes	NULL
(	NULL
Zanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
,	NULL
and	NULL
on	NULL
purified	NULL
recombinant	NULL
AP-2	NULL
«	NULL
(	NULL
Zanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
using	NULL
a	NULL
labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
AP-2	NULL
binding	NULL
site	NULL
5	NULL
of	NULL
the	NULL
B2	NULL
promoter	NULL
.	NULL

Addition	NULL
of	NULL
anti-AP-2	NULL
antibody	NULL
shifted	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
AP-2	NULL
«	NULL
protein-DNA	NULL
complex	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
mobility	NULL
of	NULL
complexes	NULL
from	NULL
the	NULL
THP-1	NULL
and	NULL
U-987	NULL
nuclear	NULL
extracts	NULL
(	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
)	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
antibody	NULL
.	NULL

(	NULL
The	NULL
slight	NULL
reduction	NULL
in	NULL
signal	NULL
between	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
was	NULL
not	NULL
seen	NULL
consistently	NULL
and	NULL
most	NULL
likely	NULL
is	NULL
an	NULL
artifact	NULL
of	NULL
uneven	NULL
gel	NULL
loading	NULL
.	NULL
)	NULL

the	NULL
factor	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
mobility	NULL
shift	NULL
and	NULL
supershift	NULL
assays	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
promonocytic	NULL
cell	NULL
line	NULL
U-987	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Like	NULL
THP-1	NULL
cells	NULL
,	NULL
U-987	NULL
nuclear	NULL
extracts	NULL
contained	NULL
a	NULL
protein	NULL
that	NULL
formed	NULL
complexes	NULL
with	NULL
AP-2	NULL
consensus	NULL
binding	NULL
sequences	NULL
,	NULL
but	NULL
showed	NULL
a	NULL
higher	NULL
mobility	NULL
than	NULL
AP-2	NULL
«	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
and	NULL
did	NULL
not	NULL
exhibit	NULL
a	NULL
mobility	NULL
supershift	NULL
with	NULL
the	NULL
anti-AP-2	NULL
«	NULL
antibody	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
from	NULL
the	NULL
THP-1	NULL
and	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
mobility	NULL
supershift	NULL
with	NULL
addition	NULL
of	NULL
as	NULL
much	NULL
as	NULL
5	NULL
ug	NULL
of	NULL
anti-AP-2	NULL
antibody	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
AP-2-like	NULL
factors	NULL
have	NULL
not	NULL
been	NULL
well	NULL
studied	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
possibility	NULL
that	NULL
THP-1	NULL
cells	NULL
express	NULL
novel	NULL
proteins	NULL
with	NULL
homology	NULL
to	NULL
AP-2	NULL
DNA-binding	NULL
domains	NULL
.	NULL

A	NULL
THP-1	NULL
macrophage	NULL
library	NULL
was	NULL
created	NULL
and	NULL
screened	NULL
at	NULL
low	NULL
stringency	NULL
using	NULL
a	NULL
cDNA	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
AP-2	NULL
«	NULL
.	NULL

Three	NULL
plaques	NULL
were	NULL
isolated	NULL
from	NULL
approximately	NULL
1	NULL
X	NULL
10°	NULL
screened	NULL
plaques	NULL
that	NULL
exhibited	NULL
a	NULL
positive	NULL
signal	NULL
through	NULL
three	NULL
rounds	NULL
of	NULL
screening	NULL
.	NULL

All	NULL
three	NULL
recombinant	NULL
phage	NULL
plaques	NULL
contained	NULL
the	NULL
same	NULL
in-sert	NULL
,	NULL
which	NULL
encoded	NULL
portions	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
3'-untranslated	NULL
region	NULL
of	NULL
AP-2	NULL
«	NULL
(	NULL
nucleotides	NULL
1184-2103	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
THP-1	NULL
cells	NULL
express	NULL
AP-2	NULL
«	NULL
,	NULL
even	NULL
though	NULL
the	NULL
predominant	NULL
DNA-binding	NULL
protein	NULL
in	NULL
the	NULL
mobility	NULL
shift	NULL
assays	NULL
appeared	NULL
to	NULL
be	NULL
a	NULL
distinct	NULL
factor	NULL
.	NULL

To	NULL
address	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
monocytic	NULL
factor	NULL
was	NULL
indeed	NULL
AP-2	NULL
@	NULL
,	NULL
but	NULL
was	NULL
exhibiting	NULL
altered	NULL
mobility	NULL
and	NULL
immu-noreactivity	NULL
due	NULL
to	NULL
effects	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
,	NULL
we	NULL
performed	NULL
experiments	NULL
in	NULL
which	NULL
recombinant	NULL
AP-2	NULL
«	NULL
was	NULL
added	NULL
to	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
used	NULL
to	NULL
perform	NULL
mobility	NULL
LANE	NULL
1__2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
THP-1	NULL
extract	NULL
:	NULL
=	NULL
oop	NULL
oop	NULL
o-	NULL
-of	NULL
Recomb	NULL
.	NULL

-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
Anti-AP-2	NULL
Ab	NULL
:	NULL
-o-	NULL
of-	NULL
#	NULL
$	NULL
7	NULL
+	NULL
+	NULL
+	NULL
<	NULL
-	NULL
AP-2	NULL
+	NULL
Ab	NULL
u	NULL
<	NULL
-	NULL
AP-2	NULL
UW	NULL
:	NULL
H	NULL
*-	NULL
THP-1	NULL
factor	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Mobility	NULL
shift	NULL
analysis	NULL
of	NULL
purified	NULL
AP-2	NULL
mixed	NULL
with	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
.	NULL

Mobility	NULL
shift	NULL
and	NULL
antibody	NULL
supershift	NULL
analyses	NULL
were	NULL
performed	NULL
on	NULL
THP-1	NULL
monocyte	NULL
nuclear	NULL
extract	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
recombinant	NULL
AP-2	NULL
«	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
and	NULL
a	NULL
mixture	NULL
of	NULL
THP-1	NULL
extract	NULL
and	NULL
AP-2	NULL
«	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
using	NULL
a	NULL
labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
AP-2	NULL
binding	NULL
site	NULL
5	NULL
of	NULL
the	NULL
B2	NULL
promoter	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
THP-1	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
assay	NULL
mixture	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
anti-AP-2	NULL
antibody	NULL
to	NULL
shift	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
AP-2	NULL
@	NULL
protein-DNA	NULL
complex	NULL
(	NULL
Zanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

shift	NULL
and	NULL
supershift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

When	NULL
incubated	NULL
with	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
,	NULL
AP-2	NULL
«	NULL
retained	NULL
its	NULL
original	NULL
mobility	NULL
and	NULL
ability	NULL
to	NULL
react	NULL
with	NULL
the	NULL
anti-AP-2	NULL
«	NULL
antibody	NULL
,	NULL
whereas	NULL
the	NULL
monocytic	NULL
factor	NULL
was	NULL
unaffected	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

These	NULL
data	NULL
,	NULL
along	NULL
with	NULL
those	NULL
shown	NULL
in	NULL
Figs	NULL
.	NULL

6-8	NULL
,	NULL
indicate	NULL
that	NULL
the	NULL
predominant	NULL
factor	NULL
in	NULL
THP-1	NULL
nuclei	NULL
that	NULL
binds	NULL
to	NULL
AP-2	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
B2	NULL
promoter	NULL
is	NULL
distinct	NULL
from	NULL
AP-2	NULL
.	NULL

DISCUSSION	NULL
Leukemic	NULL
cell	NULL
lines	NULL
of	NULL
the	NULL
myeloid	NULL
lineage	NULL
,	NULL
such	NULL
as	NULL
THP-1	NULL
,	NULL
have	NULL
served	NULL
as	NULL
excellent	NULL
tools	NULL
in	NULL
studies	NULL
of	NULL
the	NULL
terminal	NULL
differentiation	NULL
processes	NULL
of	NULL
hematopoietic	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
AP-2	NULL
binding	NULL
sites	NULL
are	NULL
essential	NULL
for	NULL
amplification	NULL
of	NULL
V-ATPase	NULL
B2	NULL
subunit	NULL
transcription	NULL
during	NULL
macrophage	NULL
differentiation	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
nuclear	NULL
factor	NULL
in	NULL
THP-1	NULL
cells	NULL
that	NULL
bind	NULL
to	NULL
these	NULL
sites	NULL
and	NULL
whose	NULL
binding	NULL
activity	NULL
increases	NULL
following	NULL
differentiation	NULL
of	NULL
THP-1	NULL
cells	NULL
into	NULL
macrophages	NULL
.	NULL

Our	NULL
results	NULL
therefore	NULL
suggest	NULL
that	NULL
a	NULL
factor	NULL
related	NULL
to	NULL
the	NULL
AP-2	NULL
family	NULL
of	NULL
factors	NULL
is	NULL
involved	NULL
in	NULL
gene	NULL
regulation	NULL
during	NULL
macrophage	NULL
differentiation	NULL
.	NULL

The	NULL
predominant	NULL
protein	NULL
from	NULL
THP-1	NULL
cell	NULL
nuclear	NULL
extracts	NULL
forming	NULL
protein-DNA	NULL
complexes	NULL
with	NULL
AP-2	NULL
binding	NULL
sites	NULL
,	NULL
however	NULL
,	NULL
is	NULL
a	NULL
novel	NULL
factor	NULL
distinct	NULL
from	NULL
AP-2	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
implicated	NULL
transcription	NULL
factors	NULL
from	NULL
multiple	NULL
gene	NULL
families	NULL
as	NULL
critical	NULL
for	NULL
terminal	NULL
differentiation	NULL
of	NULL
macrophages	NULL
.	NULL

These	NULL
factors	NULL
include	NULL
members	NULL
of	NULL
the	NULL
STAT	NULL
(	NULL
89	NULL
)	NULL
and	NULL
C/EBP	NULL
(	NULL
40	NULL
)	NULL
families	NULL
;	NULL
Pu.1	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
(	NULL
41	NULL
)	NULL
;	NULL
and	NULL
Egr-1	NULL
,	NULL
a	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
(	NULL
42	NULL
)	NULL
,	NULL
among	NULL
others	NULL
.	NULL

Although	NULL
the	NULL
role	NULL
of	NULL
transcription	NULL
factor	NULL
AP-2	NULL
in	NULL
terminal	NULL
differentiation	NULL
has	NULL
been	NULL
elucidated	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
neuroectodermal	NULL
and	NULL
epidermal	NULL
cells	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
,	NULL
the	NULL
role	NULL
of	NULL
AP-2	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
180	NULL
AP-2	NULL
Binding	NULL
Sites	NULL
Regulate	NULL
V-ATPase	NULL
B2	NULL
Subunit	NULL
Expression	NULL
in	NULL
monocytic	NULL
differentiation	NULL
and	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
addressed	NULL
in	NULL
only	NULL
a	NULL
few	NULL
studies	NULL
that	NULL
have	NULL
used	NULL
the	NULL
U-937	NULL
cell	NULL
model	NULL
.	NULL

AP-2	NULL
binding	NULL
sites	NULL
were	NULL
found	NULL
to	NULL
be	NULL
required	NULL
for	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
expression	NULL
induced	NULL
by	NULL
granulocyte-macro-phage	NULL
colony-stimulating	NULL
factor	NULL
but	NULL
not	NULL
by	NULL
phorbol	NULL
ester	NULL
(	NULL
45	NULL
)	NULL
.	NULL

AP-2	NULL
binding	NULL
sequences	NULL
were	NULL
also	NULL
found	NULL
not	NULL
to	NULL
have	NULL
any	NULL
enhancer	NULL
activity	NULL
for	NULL
transcription	NULL
of	NULL
downstream	NULL
reporters	NULL
during	NULL
phorbol	NULL
ester-induced	NULL
differentiation	NULL
of	NULL
U-9837	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
findings	NULL
appear	NULL
to	NULL
conflict	NULL
with	NULL
our	NULL
results	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
THP-1	NULL
cells	NULL
closely	NULL
mimic	NULL
primary	NULL
blood	NULL
monocytes	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
express	NULL
V-ATPase	NULL
during	NULL
differentiation	NULL
,	NULL
whereas	NULL
U-937	NULL
cells	NULL
do	NULL
not	NULL
(	NULL
18	NULL
)	NULL
.	NULL
``	NULL

The	NULL
mechanisms	NULL
that	NULL
cause	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
B2	NULL
subunit	NULL
in	NULL
primary	NULL
blood	NULL
monocytes	NULL
and	NULL
phorbol	NULL
ester-induced	NULL
THP-1	NULL
cells	NULL
therefore	NULL
may	NULL
not	NULL
be	NULL
functional	NULL
in	NULL
phorbol	NULL
ester-treated	NULL
U-937	NULL
cells	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
AP-2	NULL
site-binding	NULL
activity	NULL
was	NULL
lower	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
phorbol	NULL
ester-treated	NULL
U-937	NULL
cells	NULL
than	NULL
from	NULL
control	NULL
U-937	NULL
promonocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
of	NULL
the	NULL
V-ATPase	NULL
B2	NULL
subunit	NULL
contains	NULL
eight	NULL
functional	NULL
AP-2	NULL
binding	NULL
sites	NULL
,	NULL
and	NULL
at	NULL
least	NULL
one	NULL
of	NULL
these	NULL
sites	NULL
is	NULL
necessary	NULL
for	NULL
increased	NULL
expression	NULL
from	NULL
the	NULL
B2	NULL
promoter	NULL
during	NULL
macrophage	NULL
differentiation	NULL
.	NULL

We	NULL
have	NULL
not	NULL
determined	NULL
if	NULL
site	NULL
1	NULL
is	NULL
the	NULL
only	NULL
active	NULL
site	NULL
in	NULL
the	NULL
B2	NULL
promoter	NULL
nor	NULL
if	NULL
other	NULL
downstream	NULL
sequences	NULL
are	NULL
active	NULL
in	NULL
vivo	NULL
.	NULL

Promoters	NULL
containing	NULL
site	NULL
1	NULL
alone	NULL
(	NULL
-317	NULL
to	NULL
-124	NULL
)	NULL
showed	NULL
transcriptional	NULL
activity	NULL
somewhat	NULL
less	NULL
than	NULL
those	NULL
containing	NULL
additional	NULL
AP-2	NULL
binding	NULL
sites	NULL
and	NULL
an	NULL
Spl	NULL
site	NULL
(	NULL
-317	NULL
to	NULL
-96	NULL
;	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
but	NULL
these	NULL
differences	NULL
did	NULL
not	NULL
reach	NULL
statistical	NULL
significance	NULL
.	NULL

Four	NULL
of	NULL
the	NULL
AP-2	NULL
binding	NULL
sites	NULL
(	NULL
sites	NULL
2-5	NULL
)	NULL
are	NULL
in	NULL
such	NULL
close	NULL
proximity	NULL
to	NULL
Spl-binding	NULL
sites	NULL
that	NULL
interference	NULL
,	NULL
due	NULL
to	NULL
binding	NULL
of	NULL
Spl	NULL
,	NULL
is	NULL
likely	NULL
to	NULL
occur	NULL
.	NULL

We	NULL
have	NULL
tested	NULL
this	NULL
by	NULL
performing	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
that	NULL
contains	NULL
AP-2	NULL
binding	NULL
sites	NULL
4	NULL
and	NULL
5	NULL
and	NULL
the	NULL
overlapping	NULL
Spl-binding	NULL
site	NULL
.	NULL

When	NULL
incubated	NULL
with	NULL
THP-1	NULL
monocyte	NULL
or	NULL
macrophage	NULL
nuclear	NULL
extracts	NULL
,	NULL
the	NULL
only	NULL
detectable	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
were	NULL
with	NULL
Spl	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Spl	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
interferes	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
THP-1	NULL
factor	NULL
to	NULL
AP-2	NULL
sites	NULL
4	NULL
and	NULL
5	NULL
.	NULL

Competition	NULL
by	NULL
transcription	NULL
factors	NULL
for	NULL
adjacent	NULL
and	NULL
overlapping	NULL
binding	NULL
sites	NULL
has	NULL
been	NULL
noted	NULL
previously	NULL
for	NULL
several	NULL
promoters	NULL
and	NULL
is	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
action	NULL
of	NULL
factors	NULL
can	NULL
be	NULL
regulated	NULL
(	NULL
47-49	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
of	NULL
promoter	NULL
using	NULL
the	NULL
nuclear	NULL
extracts	NULL
will	NULL
be	NULL
required	NULL
,	NULL
however	NULL
,	NULL
for	NULL
a	NULL
direct	NULL
assessment	NULL
of	NULL
protein-DNA	NULL
interactions	NULL
in	NULL
the	NULL
B2	NULL
subunit	NULL
promoter	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
factor	NULL
from	NULL
THP-1	NULL
and	NULL
U-937	NULL
cell	NULL
nuclei	NULL
identified	NULL
here	NULL
is	NULL
unknown	NULL
.	NULL

A	NULL
probe	NULL
containing	NULL
the	NULL
conserved	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
AP-2	NULL
«	NULL
that	NULL
was	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
THP-1	NULL
cell	NULL
cDNA	NULL
library	NULL
at	NULL
low	NULL
stringency	NULL
hybridized	NULL
only	NULL
to	NULL
a	NULL
single	NULL
gene	NULL
product	NULL
,	NULL
AP-2	NULL
«	NULL
itself	NULL
.	NULL

Since	NULL
AP-2	NULL
«	NULL
is	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
why	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

The	NULL
most	NULL
likely	NULL
explanation	NULL
is	NULL
that	NULL
the	NULL
THP-1	NULL
factor	NULL
binds	NULL
AP-2	NULL
consensus	NULL
sequences	NULL
in	NULL
the	NULL
B2	NULL
promoter	NULL
with	NULL
a	NULL
higher	NULL
affinity	NULL
than	NULL
AP-2	NULL
«	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

When	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
using	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
that	NULL
binds	NULL
strongly	NULL
to	NULL
purified	NULL
AP-2	NULL
«	NULL
(	NULL
the	NULL
hMtlla	NULL
BLE	NULL
site	NULL
)	NULL
,	NULL
several	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
formed	NULL
,	NULL
one	NULL
of	NULL
which	NULL
was	NULL
nearly	NULL
identical	NULL
in	NULL
size	NULL
to	NULL
the	NULL
complex	NULL
formed	NULL
with	NULL
recombinant	NULL
AP-2	NULL
«	NULL
.	NULL

In	NULL
experiments	NULL
using	NULL
the	NULL
site	NULL
1	NULL
or	NULL
site	NULL
5	NULL
probes	NULL
,	NULL
a	NULL
barely	NULL
detectable	NULL
protein-DNA	NULL
complex	NULL
was	NULL
occasionally	NULL
present	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
the	NULL
AP-2ochMtlla	NULL
BLE	NULL
complex	NULL
,	NULL
but	NULL
it	NULL
was	NULL
not	NULL
observed	NULL
reproducibly	NULL
enough	NULL
to	NULL
allow	NULL
determination	NULL
of	NULL
its	NULL
identity	NULL
.	NULL

Although	NULL
these	NULL
studies	NULL
have	NULL
not	NULL
excluded	NULL
the	NULL
possibility	NULL
that	NULL
*	NULL
B.	NULL
S.	NULL
Lee	NULL
and	NULL
S.	NULL
L.	NULL
Gluck	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

AP-2a	NULL
has	NULL
a	NULL
role	NULL
in	NULL
B2	NULL
transcription	NULL
in	NULL
vivo	NULL
,	NULL
our	NULL
experiments	NULL
suggest	NULL
that	NULL
the	NULL
THP-1	NULL
factor	NULL
identified	NULL
here	NULL
is	NULL
the	NULL
predominant	NULL
activator	NULL
of	NULL
the	NULL
B2	NULL
promoter	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
.	NULL

Preliminary	NULL
studies	NULL
indicate	NULL
that	NULL
a	NULL
factor	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
described	NULL
here	NULL
is	NULL
present	NULL
in	NULL
differentiated	NULL
bone	NULL
marrow	NULL
and	NULL
spleen	NULL
cell	NULL
cultures	NULL
enriched	NULL
for	NULL
osteoclasts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Efforts	NULL
to	NULL
purify	NULL
this	NULL
factor	NULL
and	NULL
determine	NULL
its	NULL
identity	NULL
are	NULL
in	NULL
progress	NULL
.	NULL

The	NULL
B2	NULL
isoform	NULL
of	NULL
the	NULL
vacuolar	NULL
H*-ATPase	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
``	NULL
housekeeping	NULL
``	NULL
gene	NULL
product	NULL
,	NULL
residing	NULL
in	NULL
the	NULL
V-ATPases	NULL
that	NULL
acidify	NULL
the	NULL
intracellular	NULL
membranes	NULL
of	NULL
vertebrate	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
16	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Many	NULL
housekeeping	NULL
genes	NULL
contain	NULL
G	NULL
+	NULL
C-rich	NULL
TATA-less	NULL
promoters	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
B2	NULL
subunit	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
most	NULL
housekeeping	NULL
genes	NULL
,	NULL
however	NULL
,	NULL
the	NULL
V-ATPase	NULL
B2	NULL
subunit	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
a	NULL
small	NULL
population	NULL
of	NULL
cells	NULL
that	NULL
are	NULL
specialized	NULL
for	NULL
proton	NULL
secretion	NULL
,	NULL
such	NULL
as	NULL
macrophages	NULL
,	NULL
osteoclasts	NULL
,	NULL
and	NULL
the	NULL
renal	NULL
proximal	NULL
tubule	NULL
,	NULL
in	NULL
cells	NULL
that	NULL
maintain	NULL
high	NULL
rates	NULL
of	NULL
endocytosis	NULL
and	NULL
exocytosis	NULL
,	NULL
including	NULL
macrophages	NULL
and	NULL
proximal	NULL
tubule	NULL
cells	NULL
,	NULL
and	NULL
in	NULL
cells	NULL
that	NULL
require	NULL
V-ATPase	NULL
activity	NULL
for	NULL
solute	NULL
transport	NULL
,	NULL
such	NULL
as	NULL
neurons	NULL
.	NULL

AP-2-like	NULL
proteins	NULL
may	NULL
provide	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
amplified	NULL
expression	NULL
of	NULL
the	NULL
V-ATPase	NULL
may	NULL
occur	NULL
in	NULL
specific	NULL
cell	NULL
types	NULL
.	NULL

It	NULL
is	NULL
perhaps	NULL
not	NULL
coincidental	NULL
that	NULL
the	NULL
kidney	NULL
and	NULL
brain	NULL
,	NULL
which	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
B2	NULL
mRNA	NULL
,	NULL
also	NULL
express	NULL
very	NULL
high	NULL
levels	NULL
of	NULL
AP-2	NULL
proteins	NULL
during	NULL
development	NULL
and	NULL
in	NULL
adulthood	NULL
.	NULL

Our	NULL
studies	NULL
may	NULL
have	NULL
identified	NULL
a	NULL
unique	NULL
transcription	NULL
factor	NULL
,	NULL
binding	NULL
to	NULL
AP-2	NULL
sites	NULL
,	NULL
that	NULL
confers	NULL
the	NULL
capacity	NULL
for	NULL
cells	NULL
to	NULL
maintain	NULL
high	NULL
levels	NULL
of	NULL
B2	NULL
expression	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Kenneth	NULL
Murphy	NULL
for	NULL
use	NULL
of	NULL
the	NULL
luminometer	NULL
,	NULL
K.	NULL
Amanda	NULL
Wilson	NULL
for	NULL
technical	NULL
support	NULL
,	NULL
and	NULL
Dr.	NULL
Rein-hard	NULL
Buettner	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

REFERENCES	NULL
Nelson	NULL
,	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

4	NULL
,	NULL
654-660	NULL
.	NULL

Nelson	NULL
,	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Bioenerg	NULL
.	NULL

Biomembr	NULL
.	NULL

24	NULL
,	NULL
407-414	NULL
.	NULL

Arai	NULL
,	NULL
H.	NULL
,	NULL
Terres	NULL
,	NULL
G.	NULL
,	NULL
Pink	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Forgac	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
8796-8802	NULL
4	NULL
.	NULL

Wang	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Moriyama	NULL
,	NULL
Y.	NULL
,	NULL
Mandel	NULL
,	NULL
M.	NULL
,	NULL
Hulmes	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Pan	NULL
,	NULL
Y.-C.	NULL
E.	NULL
,	NULL
Danho	NULL
,	NULL
W.	NULL
,	NULL
Nelson	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Nelson	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
17638-17642	NULL
5	NULL
.	NULL

Supek	NULL
,	NULL
F.	NULL
,	NULL
Supekova	NULL
,	NULL
L.	NULL
,	NULL
Beltran	NULL
,	NULL
C.	NULL
,	NULL
Nelson	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Nelson	NULL
,	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Anz	NULL
.	NULL

N.	NULL
Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

671	NULL
,	NULL
284-292	NULL
6	NULL
.	NULL

Manolson	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Proteau	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
E.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Biol	NULL
.	NULL

172	NULL
,	NULL
105-112	NULL
.	NULL

Zhang	NULL
,	NULL
J.	NULL
,	NULL
Feng	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Forgac	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
23518-23523	NULL
.	NULL

Gluck	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Underhill	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Iyori	NULL
,	NULL
M.	NULL
,	NULL
Holliday	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Kostrominova	NULL
,	NULL
T.	NULL
Y.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
B	NULL
.	NULL

9	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Physiol	NULL
.	NULL

58	NULL
,	NULL
427-445	NULL
9	NULL
.	NULL

Arai	NULL
,	NULL
H.	NULL
,	NULL
Berne	NULL
,	NULL
M.	NULL
,	NULL
Terres	NULL
,	NULL
G.	NULL
,	NULL
Terres	NULL
,	NULL
H.	NULL
,	NULL
Puopolo	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Forgac	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Biochemistry	NULL
26	NULL
,	NULL
6632-6638	NULL
10	NULL
.	NULL

Moriyama	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nelson	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
14723-14729	NULL
11	NULL
.	NULL

Abrahams	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Leslie	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Lutter	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Walker	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
870	NULL
,	NULL
621-628	NULL
12	NULL
.	NULL

Wang	NULL
,	NULL
Z.-Q	NULL
.	NULL

,	NULL
and	NULL
Gluck	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
21957-21965	NULL
13	NULL
.	NULL

Myers	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Forgac	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
9184-9186	NULL
14	NULL
.	NULL

Suihdhof	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Fried	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Stone	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Johnston	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Xie	NULL
,	NULL
X.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
6067-6071	NULL
15	NULL
.	NULL

Bernasconi	NULL
,	NULL
P.	NULL
,	NULL
Rausch	NULL
,	NULL
T.	NULL
,	NULL
Struve	NULL
,	NULL
I.	NULL
,	NULL
Morgan	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Taiz	NULL
,	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
17428-17481	NULL
16	NULL
.	NULL

Nelson	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Guo	NULL
,	NULL
X.	NULL
L.	NULL
,	NULL
Masood	NULL
,	NULL
K.	NULL
,	NULL
Brown	NULL
,	NULL
D.	NULL
,	NULL
Kalkbrenner	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gluck	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
8541-8545	NULL
17	NULL
.	NULL

Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
125-133	NULL
18	NULL
.	NULL

Lee	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
Underhill	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Crane	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
Gluck	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
7320-7829	NULL
19	NULL
.	NULL

Swallow	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Grinstein	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Rotstein	NULL
,	NULL
O.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
7645-7654	NULL
20	NULL
.	NULL

Swallow	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Grinstein	NULL
,	NULL
S.	NULL
,	NULL
Sudsbury	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Rotstein	NULL
,	NULL
O.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Surgery	NULL
108	NULL
,	NULL
363-369	NULL
21	NULL
.	NULL

Blair	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
Teitelbaum	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Ghiselli	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Gluck	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
245	NULL
,	NULL
855-857	NULL
22	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Wang	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
50	NULL
,	NULL
847-861	NULL
28	NULL
.	NULL

Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
251-260	NULL
24	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Timmons	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Hebert	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Rigby	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
105-119	NULL
25	NULL
.	NULL

Buettner	NULL
,	NULL
R.	NULL
,	NULL
Kannan	NULL
,	NULL
P.	NULL
,	NULL
Imhof	NULL
,	NULL
A.	NULL
,	NULL
Bauer	NULL
,	NULL
R.	NULL
,	NULL
Yim	NULL
,	NULL
S.	NULL
O.	NULL
,	NULL
Glockshuber	NULL
,	NULL
R.	NULL
,	NULL
Van	NULL
Dyke	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
and	NULL
Tainsky	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
4174-4185	NULL
26	NULL
.	NULL

Meier	NULL
,	NULL
P.	NULL
,	NULL
Koedood	NULL
,	NULL
M.	NULL
,	NULL
Philipp	NULL
,	NULL
J.	NULL
,	NULL
Fontana	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Mitchell	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

169	NULL
,	NULL
1-14	NULL
27	NULL
.	NULL

Moser	NULL
,	NULL
M.	NULL
,	NULL
Imhof	NULL
,	NULL
A.	NULL
,	NULL
Pscherer	NULL
,	NULL
A.	NULL
,	NULL
Bauer	NULL
,	NULL
R.	NULL
,	NULL
Amselgruber	NULL
,	NULL
W.	NULL
,	NULL
Sinowatz	NULL
,	NULL
F.	NULL
,	NULL
Hofstadter	NULL
,	NULL
F.	NULL
,	NULL
Schule	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Buettner	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Development	NULL
121	NULL
,	NULL
2779-2788	NULL
28	NULL
.	NULL

Williams	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
670-682	NULL
g	NULL
b	NULL
go	NULL
=	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

82	NULL
.	NULL

38	NULL
.	NULL

84	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

AP-2	NULL
Binding	NULL
Sites	NULL
Regulate	NULL
V-ATPase	NULL
B2	NULL
Subunit	NULL
Expression	NULL
Tsuchiya	NULL
,	NULL
S.	NULL
,	NULL
Kobayashi	NULL
,	NULL
Y.	NULL
,	NULL
Goto	NULL
,	NULL
Y.	NULL
,	NULL
Okumura	NULL
,	NULL
H.	NULL
,	NULL
Nakae	NULL
,	NULL
S.	NULL
,	NULL
Konno	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tada	NULL
,	NULL
K.	NULL
(	NULL
1982	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

42	NULL
,	NULL
1530-1536	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Brand	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
1517-1526	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
(	NULL
1987	NULL
)	NULL
in	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
(	NULL
Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Struhl	NULL
,	NULL
K.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

9.6.1-9.6.9	NULL
,	NULL
Wiley	NULL
Interscience	NULL
,	NULL
New	NULL
York	NULL
Neumann	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Morency	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Russian	NULL
,	NULL
K.	NULL
O	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
BioTechniques	NULL
5	NULL
,	NULL
444-447	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Lee	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Bindereif	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Gene	NULL
Anal	NULL
.	NULL

Tech	NULL
.	NULL

5	NULL
,	NULL
22-31	NULL
Kannan	NULL
,	NULL
P.	NULL
,	NULL
Buettner	NULL
,	NULL
R.	NULL
,	NULL
Chiao	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Yim	NULL
,	NULL
S.	NULL
O.	NULL
,	NULL
Sarkiss	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Tainsky	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
1258-1269	NULL
Chen	NULL
,	NULL
H.-M.	NULL
,	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Scheibe	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Zhang	NULL
,	NULL
D.-E.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
82830-8239	NULL
Roberts	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Boundy	NULL
,	NULL
A.	NULL
,	NULL
O'Hare	NULL
,	NULL
P.	NULL
,	NULL
Pizzorno	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Ciufo	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Hayward	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
4807-4320	NULL
Liebermann	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Hoffman	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Stem	NULL
Cells	NULL
12	NULL
,	NULL
352-369	NULL
Barahmand-Pour	NULL
,	NULL
F.	NULL
,	NULL
Meinke	NULL
,	NULL
A.	NULL
,	NULL
Kieslinger	NULL
,	NULL
M.	NULL
,	NULL
Eilers	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Decker	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

211	NULL
,	NULL
121-128	NULL
40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

181	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Yoshida	NULL
,	NULL
K.	NULL
,	NULL
Umemoto	NULL
,	NULL
M.	NULL
,	NULL
Yoneda	NULL
,	NULL
Y.	NULL
,	NULL
Shirafuji	NULL
,	NULL
N.	NULL
,	NULL
Fujiwara	NULL
,	NULL
H.	NULL
,	NULL
Suematsu	NULL
,	NULL
S.	NULL
,	NULL
Yoshida	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
353-361	NULL
Simon	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Olson	NULL
,	NULL
M.	NULL
,	NULL
Scott	NULL
,	NULL
E.	NULL
,	NULL
Hack	NULL
,	NULL
A.	NULL
,	NULL
Su	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Singh	NULL
,	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

211	NULL
,	NULL
113-119	NULL
Krishnaraju	NULL
,	NULL
K.	NULL
,	NULL
Nguyen	NULL
,	NULL
H.	NULL
Q.	NULL
,	NULL
Liebermann	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Hoffman	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
5499-5507	NULL
Leask	NULL
,	NULL
A.	NULL
,	NULL
Byrne	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Fuchs	NULL
,	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7948-7952	NULL
Philipp	NULL
,	NULL
J.	NULL
,	NULL
Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Malipiero	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Fontana	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

165	NULL
,	NULL
602-614	NULL
Rhoades	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Cai	NULL
,	NULL
S.	NULL
,	NULL
Golub	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Economou	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

161	NULL
,	NULL
125-181	NULL
Adler	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

164	NULL
,	NULL
26-34	NULL
Zinn	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
45	NULL
,	NULL
611-618	NULL
Lichtsteiner	NULL
,	NULL
S.	NULL
,	NULL
Wuarin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Schibler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
963-978	NULL
Schaufele	NULL
,	NULL
F.	NULL
,	NULL
West	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
and	NULL
ReudeThuber	NULL
,	NULL
T.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
17189-17196	NULL
Lee	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
Holliday	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Ojikutu	NULL
,	NULL
B.	NULL
,	NULL
Krits	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Gluck	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

270	NULL
,	NULL
C382-C388	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
A	NULL
Novel	NULL
Transcription	NULL
Factor	NULL
Regulates	NULL
Expression	NULL
of	NULL
the	NULL
Vacuolar	NULL
H*-ATPase	NULL
B2	NULL
Subunit	NULL
through	NULL
AP-2	NULL
Sites	NULL
during	NULL
Monocytic	NULL
Differentiation	NULL
Beth	NULL
S.	NULL
Lee	NULL
,	NULL
Irina	NULL
Krits	NULL
,	NULL
Monica	NULL
K.	NULL
Crane-Zelkovic	NULL
and	NULL
Stephen	NULL
L.	NULL
Gluck	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:174-181.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.1.174	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/1/1	NULL
74	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
49	NULL
references	NULL
,	NULL
25	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
74	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

